Autophagy and ALS: mechanistic insights and therapeutic implications

References

• De Duve C, Wattiaux R. Functions of lysosomes. Annu Rev Physiol. 1966;28(1):435–492.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ. Autophagy revisited: a conversation with Christian de Duve. Autophagy. 2008;4(6):740–743.
   PubMed Web of Science ®Google Scholar
• Fimia GM, Stoykova A, Romagnoli A, et al. Ambra1 regulates autophagy and development of the nervous system. Nature. 2007;447(7148):1121–1125. DOI:https://doi.org/10.1038/nature05925.
   PubMed Web of Science ®Google Scholar
• Gan B, Peng X, Nagy T, et al. Role of FIP200 in cardiac and liver development and its regulation of TNFalpha and TSC-mTOR signaling pathways. J Cell Biol. 2006;175(1):121–133. DOI:https://doi.org/10.1083/jcb.200604129.
   PubMed Web of Science ®Google Scholar
• Kuma A, Hatano M, Matsui M, et al. The role of autophagy during the early neonatal starvation period. Nature. 2004;432(7020):1032–1036. DOI:https://doi.org/10.1038/nature03029.
   PubMed Web of Science ®Google Scholar
• Qu X, Yu J, Bhagat G, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest. 2003;112(12):1809–1820. DOI:https://doi.org/10.1172/JCI20039.
   PubMed Web of Science ®Google Scholar
• Saitoh T, Fujita N, Jang MH, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature. 2008;456(7219):264–268. DOI:https://doi.org/10.1038/nature07383.
   PubMed Web of Science ®Google Scholar
• Tsukamoto S, Kuma A, Murakami M, et al. Autophagy is essential for preimplantation development of mouse embryos. Science. 2008;321(5885):117–120. DOI:https://doi.org/10.1126/science.1154822.
   PubMed Web of Science ®Google Scholar
• Yue Z, Jin S, Yang C, et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A. 2003;100(25):15077–15082. DOI:https://doi.org/10.1073/pnas.2436255100.
   PubMed Web of Science ®Google Scholar
• Hughes T, Rusten TE. Origin and evolution of self-consumption: autophagy. Adv Exp Med Biol. 2007;607:111–118.
   PubMed Web of Science ®Google Scholar
• Moruno-Manchon JF, Uzor NE, Ambati CR, et al. Sphingosine kinase 1-associated autophagy differs between neurons and astrocytes. Cell Death Dis. 2018;9(5):521. DOI:https://doi.org/10.1038/s41419-018-0599-5.
   PubMed Web of Science ®Google Scholar
• Valera E, Spencer B, Mott J, et al. MicroRNA-101 modulates autophagy and oligodendroglial alpha-synuclein accumulation in multiple system atrophy. Front Mol Neurosci. 2017;10:329.
   PubMed Web of Science ®Google Scholar
• Vaccari I, Carbone A, Previtali SC, et al. Loss of Fig4 in both Schwann cells and motor neurons contributes to CMT4J neuropathy. Hum Mol Genet. 2015;24(2):383–396. DOI:https://doi.org/10.1093/hmg/ddu451.
   PubMed Web of Science ®Google Scholar
• Bremer J, O’Connor T, Tiberi C, et al. Ablation of Dicer from murine Schwann cells increases their proliferation while blocking myelination. PLoS One. 2010;5(8):e12450. DOI:https://doi.org/10.1371/journal.pone.0012450.
   PubMed Web of Science ®Google Scholar
• Shi G, Shi J, Liu K, et al. Increased miR-195 aggravates neuropathic pain by inhibiting autophagy following peripheral nerve injury. Glia. 2013;61(4):504–512. DOI:https://doi.org/10.1002/glia.22451.
   PubMed Web of Science ®Google Scholar
• Jamart C, Naslain D, Gilson H, et al. Higher activation of autophagy in skeletal muscle of mice during endurance exercise in the fasted state. Am J Physiol Endocrinol Metab. 2013;305(8):E964–74. DOI:https://doi.org/10.1152/ajpendo.00270.2013.
   PubMed Web of Science ®Google Scholar
• Laporte J, Hu LJ, Kretz C, et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet. 1996;13(2):175–182. DOI:https://doi.org/10.1038/ng0696-175.
   PubMed Web of Science ®Google Scholar
• Pagano AF, Py G, Bernardi H, et al. Autophagy and protein turnover signaling in slow-twitch muscle during exercise. Med Sci Sports Exerc. 2014;46(7):1314–1325. DOI:https://doi.org/10.1249/MSS.0000000000000237.
   PubMed Web of Science ®Google Scholar
• Spaulding HR, Ludwig AK, Hollinger K, et al. PGC-1alpha overexpression increases transcription factor EB nuclear localization and lysosome abundance in dystrophin-deficient skeletal muscle. Physiol Rep. 2020;8(4):e14383. DOI:https://doi.org/10.14814/phy2.14383.
   PubMed Web of Science ®Google Scholar
• Vergne I, Roberts E, Elmaoued RA, et al. Control of autophagy initiation by phosphoinositide 3-phosphatase Jumpy. Embo J. 2009;28(15):2244–2258. DOI:https://doi.org/10.1038/emboj.2009.159.
   PubMed Web of Science ®Google Scholar
• Wang H, Dai J, Hou S, et al. Treatment of hepatocellular carcinoma with adenoviral vector-mediated Flt3 ligand gene therapy. Cancer Gene Ther. 2005;12(9):769–777. DOI:https://doi.org/10.1038/sj.cgt.7700843.
   PubMed Web of Science ®Google Scholar
• Ashrafi G, Schlehe JS, LaVoie MJ, et al. Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin. J Cell Biol. 2014;206(5):655–670. DOI:https://doi.org/10.1083/jcb.201401070.
   PubMed Web of Science ®Google Scholar
• Fu MM, Holzbaur EL. MAPK8IP1/JIP1 regulates the trafficking of autophagosomes in neurons. Autophagy. 2014;10(11):2079–2081.
   PubMed Web of Science ®Google Scholar
• Rub C, Wilkening A, Voos W. Mitochondrial quality control by the Pink1/Parkin system. Cell Tissue Res. 2017;367(1):111–123.
   PubMed Web of Science ®Google Scholar
• Stavoe AK, Hill SE, Hall DH, et al. KIF1A/UNC-104 transports ATG-9 to regulate neurodevelopment and autophagy at synapses. Dev Cell. 2016;38(2):171–185. DOI:https://doi.org/10.1016/j.devcel.2016.06.012.
   PubMed Web of Science ®Google Scholar
• Wong YC, Holzbaur EL. The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation. J Neurosci. 2014;34(4):1293–1305.
   PubMed Web of Science ®Google Scholar
• Hirano A. Neuropathology of ALS: an overview. Neurology. 1996;47(4 Suppl 2):S63–6.
   PubMed Web of Science ®Google Scholar
• Laferriere F, Polymenidou M. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis. Swiss Med Wkly. 2015;145:w14054.
   PubMed Web of Science ®Google Scholar
• Peters OM, Ghasemi M, Brown RH Jr. Emerging mechanisms of molecular pathology in ALS. J Clin Invest. 2015;125(5):1767–1779.
   PubMed Web of Science ®Google Scholar
• Shefner JM, Al-Chalabi A, Baker MR, et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol. 2020;131(8):1975–1978. DOI:https://doi.org/10.1016/j.clinph.2020.04.005.
   PubMed Web of Science ®Google Scholar
• Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal. 2014;20(3):460–473.
   PubMed Web of Science ®Google Scholar
• Chen Y, Klionsky DJ. The regulation of autophagy - unanswered questions. J Cell Sci. 2011;124(2):161–170.
   PubMed Web of Science ®Google Scholar
• Ganley IG, Lam Du H, Wang J, et al. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem. 2009;284(18):12297–12305. DOI:https://doi.org/10.1074/jbc.M900573200.
   PubMed Web of Science ®Google Scholar
• Itakura E, Mizushima N. Characterization of autophagosome formation site by a hierarchical analysis of mammalian Atg proteins. Autophagy. 2010;6(6):764–776.
   PubMed Web of Science ®Google Scholar
• Yang Z, Klionsky DJ. An overview of the molecular mechanism of autophagy. Curr Top Microbiol Immunol. 2009;335:1–32.
   PubMed Web of Science ®Google Scholar
• Jung CH, Jun CB, Ro SH, et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell. 2009;20(7):1992–2003. DOI:https://doi.org/10.1091/mbc.e08-12-1249.
   PubMed Web of Science ®Google Scholar
• Hosokawa N, Hara T, Kaizuka T, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell. 2009;20(7):1981–1991. DOI:https://doi.org/10.1091/mbc.e08-12-1248.
   PubMed Web of Science ®Google Scholar
• Burman C, Ktistakis NT. Regulation of autophagy by phosphatidylinositol 3-phosphate. FEBS Lett. 2010;584(7):1302–1312.
   PubMed Web of Science ®Google Scholar
• Itakura E, Kishi C, Inoue K, et al. Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell. 2008;19(12):5360–5372. DOI:https://doi.org/10.1091/mbc.e08-01-0080.
   PubMed Web of Science ®Google Scholar
• Geng J, Klionsky DJ. The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. ‘Protein modifications: beyond the usual suspects’ review series. EMBO Rep. 2008;9(9):859–864.
   PubMed Web of Science ®Google Scholar
• Weidberg H, Shvets E, Elazar Z. Biogenesis and cargo selectivity of autophagosomes. Annu Rev Biochem. 2011;80(1):125–156.
   PubMed Web of Science ®Google Scholar
• Yorimitsu T, Klionsky DJ. Autophagy: molecular machinery for self-eating. Cell Death Differ. 2005;12(Suppl 2):1542–1552.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728–741.
   PubMed Web of Science ®Google Scholar
• Lamb CA, Yoshimori T, Tooze SA. The autophagosome: origins unknown, biogenesis complex. Nat Rev Mol Cell Biol. 2013;14(12):759–774.
   PubMed Web of Science ®Google Scholar
• Liang C, Lee JS, Inn KS, et al. Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking. Nat Cell Biol. 2008;10(7):776–787. DOI:https://doi.org/10.1038/ncb1740.
   PubMed Web of Science ®Google Scholar
• Wurmser AE, Sato TK, Emr SD. New component of the vacuolar class C-Vps complex couples nucleotide exchange on the Ypt7 GTPase to SNARE-dependent docking and fusion. J Cell Biol. 2000;151(3):551–562.
   PubMed Web of Science ®Google Scholar
• Sardiello M, Palmieri M, Di Ronza A, et al. A gene network regulating lysosomal biogenesis and function. Science. 2009;325(5939):473–477.
   PubMed Web of Science ®Google Scholar
• Settembre C, Di Malta C, Polito VA, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332(6036):1429–1433. DOI:https://doi.org/10.1126/science.1204592.
   PubMed Web of Science ®Google Scholar
• Lapierre LR, Kumsta C, Sandri M, et al. Transcriptional and epigenetic regulation of autophagy in aging. Autophagy. 2015;11(6):867–880. DOI:https://doi.org/10.1080/15548627.2015.1034410.
   PubMed Web of Science ®Google Scholar
• Medina DL, Ballabio A. Lysosomal calcium regulates autophagy. Autophagy. 2015;11(6):970–971.
   PubMed Web of Science ®Google Scholar
• Napolitano G, Ballabio A. TFEB at a glance. J Cell Sci. 2016;129(13):2475–2481.
   PubMed Web of Science ®Google Scholar
• Puertollano R, Ferguson SM, Brugarolas J, et al. The complex relationship between TFEB transcription factor phosphorylation and subcellular localization. Embo J. 2018;37(11):11. DOI:https://doi.org/10.15252/embj.201798804.
   Web of Science ®Google Scholar
• Cuervo AM, Wong E. Chaperone-mediated autophagy: roles in disease and aging. Cell Res. 2014;24(1):92–104.
   PubMed Web of Science ®Google Scholar
• Tasset I, Cuervo AM. Role of chaperone-mediated autophagy in metabolism. FEBS J. 2016;283(13):2403–2413.
   PubMed Web of Science ®Google Scholar
• Li WW, Li J, Bao JK. Microautophagy: lesser-known self-eating. Cell Mol Life Sci. 2012;69(7):1125–1136.
   PubMed Web of Science ®Google Scholar
• Kondapalli C, Kazlauskaite A, Zhang N, et al. PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65. Open Biol. 2012;2(5):120080. DOI:https://doi.org/10.1098/rsob.120080.
   PubMed Web of Science ®Google Scholar
• Dengjel J, Abeliovich H. Roles of mitophagy in cellular physiology and development. Cell Tissue Res. 2017;367(1):95–109.
   PubMed Web of Science ®Google Scholar
• Heo JM, Ordureau A, Paulo JA, et al. The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol Cell. 2015;60(1):7–20. DOI:https://doi.org/10.1016/j.molcel.2015.08.016.
   PubMed Web of Science ®Google Scholar
• Matsumoto G, Shimogori T, Hattori N, et al. TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation. Hum Mol Genet. 2015;24(15):4429–4442. DOI:https://doi.org/10.1093/hmg/ddv179.
   PubMed Web of Science ®Google Scholar
• Davis CH, Kim KY, Bushong EA, et al. Transcellular degradation of axonal mitochondria. Proc Natl Acad Sci U S A. 2014;111(26):9633–9638. DOI:https://doi.org/10.1073/pnas.1404651111.
   PubMed Web of Science ®Google Scholar
• Decker CJ, Parker R. P-bodies and stress granules: possible roles in the control of translation and mRNA degradation. Cold Spring Harb Perspect Biol. 2012;4(9):a012286.
   PubMed Web of Science ®Google Scholar
• Erickson SL, Lykke-Andersen J. Cytoplasmic mRNP granules at a glance. J Cell Sci. 2011;124(3):293–297.
   PubMed Web of Science ®Google Scholar
• Buchan JR, Kolaitis RM, Taylor JP, et al. Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell. 2013;153(7):1461–1474. DOI:https://doi.org/10.1016/j.cell.2013.05.037.
   PubMed Web of Science ®Google Scholar
• Meyer H, Bug M, Bremer S. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat Cell Biol. 2012;14(2):117–123.
   PubMed Web of Science ®Google Scholar
• Mijaljica D, Prescott M, Devenish RJV. ATPase engagement in autophagic processes. Autophagy. 2011;7(6):666–668.
   PubMed Web of Science ®Google Scholar
• Ossareh-Nazari B, Bonizec M, Cohen M, et al. Cdc48 and Ufd3, new partners of the ubiquitin protease Ubp3, are required for ribophagy. EMBO Rep. 2010;11(7):548–554. DOI:https://doi.org/10.1038/embor.2010.74.
   PubMed Web of Science ®Google Scholar
• Kaushik S, Massey AC, Mizushima N, et al. Constitutive activation of chaperone-mediated autophagy in cells with impaired macroautophagy. Mol Biol Cell. 2008;19(5):2179–2192. DOI:https://doi.org/10.1091/mbc.e07-11-1155.
   PubMed Web of Science ®Google Scholar
• Taylor JP, Hardy J, Fischbeck KH. Toxic proteins in neurodegenerative disease. Science. 2002;296(5575):1991–1995.
   PubMed Web of Science ®Google Scholar
• Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 1998;21(12):516–520.
   PubMed Web of Science ®Google Scholar
• Ciechanover A, Kwon YT. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med. 2015;47(3):e147.
   PubMed Web of Science ®Google Scholar
• Gadad BS, Britton GB, Rao KS. Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide. J Alzheimers Dis. 2011;24(Suppl 2):223–232.
   PubMed Web of Science ®Google Scholar
• Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004;10(S7):S10–7.
   PubMed Web of Science ®Google Scholar
• Yerbury JJ, Ooi L, Dillin A, et al. Walking the tightrope: proteostasis and neurodegenerative disease. J Neurochem. 2016;137(4):489–505. DOI:https://doi.org/10.1111/jnc.13575.
   PubMed Web of Science ®Google Scholar
• Corti O, Blomgren K, Poletti A, et al. Autophagy in neurodegeneration: new insights underpinning therapy for neurological diseases. J Neurochem. 2020;154(4):354–371. DOI:https://doi.org/10.1111/jnc.15002.
   PubMed Web of Science ®Google Scholar
• Finkbeiner S. The autophagy lysosomal pathway and neurodegeneration. Cold Spring Harb Perspect Biol. 2020;12(3):3.
   Web of Science ®Google Scholar
• Frake RA, Ricketts T, Menzies FM, et al. Autophagy and neurodegeneration. J Clin Invest. 2015;125(1):65–74. DOI:https://doi.org/10.1172/JCI73944.
   PubMed Web of Science ®Google Scholar
• Heras-Sandoval D, Pérez-Rojas JM, Hernández-Damián J, et al. The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal. 2014;26(12):2694–2701. DOI:https://doi.org/10.1016/j.cellsig.2014.08.019.
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27–42.
   PubMed Web of Science ®Google Scholar
• Martini-Stoica H, Xu Y, Ballabio A, et al. The autophagy-lysosomal pathway in neurodegeneration: a TFEB perspective. Trends Neurosci. 2016;39(4):221–234. DOI:https://doi.org/10.1016/j.tins.2016.02.002.
   PubMed Web of Science ®Google Scholar
• Menzies FM, Fleming A, Caricasole A, et al. Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron. 2017;93(5):1015–1034.
   PubMed Web of Science ®Google Scholar
• Menzies FM, Fleming A, Rubinsztein DC. Compromised autophagy and neurodegenerative diseases. Nat Rev Neurosci. 2015;16(6):345–357.
   PubMed Web of Science ®Google Scholar
• Lorente Pons A, Higginbottom A, Cooper-Knock J, et al. Oligodendrocyte pathology exceeds axonal pathology in white matter in human amyotrophic lateral sclerosis. J Pathol. 2020;251(3):262–271. DOI:https://doi.org/10.1002/path.5455.
   PubMed Web of Science ®Google Scholar
• Lippai M, Lőw P. The role of the selective adaptor p62 and ubiquitin-like proteins in autophagy. Biomed Res Int. 2014;2014:832704.
   PubMed Web of Science ®Google Scholar
• Pankiv S, Clausen TH, Lamark T, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282(33):24131–24145. DOI:https://doi.org/10.1074/jbc.M702824200.
   PubMed Web of Science ®Google Scholar
• Lamark T, Svenning S, Johansen T. Regulation of selective autophagy: the p62/SQSTM1 paradigm. Essays Biochem. 2017;61(6):609–624.
   PubMed Web of Science ®Google Scholar
• Sánchez-Martín P, Komatsu M. p62/SQSTM1 - steering the cell through health and disease. J Cell Sci. 2018;131(21):21.
   Web of Science ®Google Scholar
• Long J, Garner TP, Pandya MJ, et al. Dimerisation of the UBA domain of p62 inhibits ubiquitin binding and regulates NF-kappaB signalling. J Mol Biol. 2010;396(1):178–194. DOI:https://doi.org/10.1016/j.jmb.2009.11.032.
   PubMed Web of Science ®Google Scholar
• Isogai S, Morimoto D, Arita K, et al. Crystal structure of the ubiquitin-associated (UBA) domain of p62 and its interaction with ubiquitin. J Biol Chem. 2011;286(36):31864–31874. DOI:https://doi.org/10.1074/jbc.M111.259630.
   PubMed Web of Science ®Google Scholar
• Lim J, Lachenmayer ML, Wu S, et al. Proteotoxic stress induces phosphorylation of p62/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates. PLoS Genet. 2015;11(2):e1004987. DOI:https://doi.org/10.1371/journal.pgen.1004987.
   PubMed Web of Science ®Google Scholar
• Pilli M, Arko-Mensah J, Ponpuak M, et al. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity. 2012;37(2):223–234. DOI:https://doi.org/10.1016/j.immuni.2012.04.015.
   PubMed Web of Science ®Google Scholar
• Wurzer B, Zaffagnini G, Fracchiolla D, et al. Oligomerization of p62 allows for selection of ubiquitinated cargo and isolation membrane during selective autophagy. Elife. 2015;4:e08941.
   PubMed Web of Science ®Google Scholar
• Sun D, Wu R, Zheng J, et al. Polyubiquitin chain-induced p62 phase separation drives autophagic cargo segregation. Cell Res. 2018;28(4):405–415. DOI:https://doi.org/10.1038/s41422-018-0017-7.
   PubMed Web of Science ®Google Scholar
• Zaffagnini G, Savova A, Danieli A, et al. p62 filaments capture and present ubiquitinated cargos for autophagy. Embo J. 2018;37(5):5. DOI:https://doi.org/10.15252/embj.201798308.
   Web of Science ®Google Scholar
• Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12(1):1–222.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy. 2007;3(6):542–545.
   PubMed Web of Science ®Google Scholar
• Zheng YT, Shahnazari S, Brech A, et al. The adaptor protein p62/SQSTM1 targets invading bacteria to the autophagy pathway. J Immunol. 2009;183(9):5909–5916. DOI:https://doi.org/10.4049/jimmunol.0900441.
   PubMed Web of Science ®Google Scholar
• Deng H, Dodson MW, Huang H, et al. The Parkinson’s disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc Natl Acad Sci U S A. 2008;105(38):14503–14508. DOI:https://doi.org/10.1073/pnas.0803998105.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gehrke S, Imai Y, et al. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci U S A. 2006;103(28):10793–10798. DOI:https://doi.org/10.1073/pnas.0602493103.
   PubMed Web of Science ®Google Scholar
• Geisler S, Holmström KM, Skujat D, et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol. 2010;12(2):119–131. DOI:https://doi.org/10.1038/ncb2012.
   PubMed Web of Science ®Google Scholar
• Johansen T, Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy. 2011;7(3):279–296.
   PubMed Web of Science ®Google Scholar
• Moscat J, Diaz-Meco MT. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell. 2009;137(6):1001–1004.
   PubMed Web of Science ®Google Scholar
• Sánchez-Martín P, Saito T, Komatsu M. p62/SQSTM1: ‘Jack of all trades’ in health and cancer. Febs J. 2019;286(1):8–23.
   PubMed Web of Science ®Google Scholar
• Duran A, Amanchy R, Linares JF, et al. p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol Cell. 2011;44(1):134–146. DOI:https://doi.org/10.1016/j.molcel.2011.06.038.
   PubMed Web of Science ®Google Scholar
• Linares JF, Duran A, Reina-Campos M, et al. Amino acid activation of mTORC1 by a PB1-domain-driven kinase complex cascade. Cell Rep. 2015;12(8):1339–1352. DOI:https://doi.org/10.1016/j.celrep.2015.07.045.
   PubMed Web of Science ®Google Scholar
• Linares JF, Duran A, Yajima T, et al. K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells. Mol Cell. 2013;51(3):283–296. DOI:https://doi.org/10.1016/j.molcel.2013.06.020.
   PubMed Web of Science ®Google Scholar
• Myeku N, Figueiredo-Pereira ME. Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62. J Biol Chem. 2011;286(25):22426–22440.
   PubMed Web of Science ®Google Scholar
• Sahani MH, Itakura E, Mizushima N. Expression of the autophagy substrate SQSTM1/p62 is restored during prolonged starvation depending on transcriptional upregulation and autophagy-derived amino acids. Autophagy. 2014;10(3):431–441.
   PubMed Web of Science ®Google Scholar
• Seibenhener ML, Babu JR, Geetha T, et al. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol. 2004;24(18):8055–8068. DOI:https://doi.org/10.1128/MCB.24.18.8055-8068.2004.
   PubMed Web of Science ®Google Scholar
• Lee J, Kim HR, Quinley C, et al. Autophagy suppresses interleukin-1β (IL-1β) signaling by activation of p62 degradation via lysosomal and proteasomal pathways. J Biol Chem. 2012;287(6):4033–4040.
   PubMed Web of Science ®Google Scholar
• Bellezza I, Giambanco I, Minelli A, et al. Nrf2-Keap1 signaling in oxidative and reductive stress. Biochim Biophys Acta Mol Cell Res. 2018;1865(5):721–733. DOI:https://doi.org/10.1016/j.bbamcr.2018.02.010.
   PubMed Web of Science ®Google Scholar
• Jain A, Lamark T, Sjøttem E, et al. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem. 2010;285(29):22576–22591. DOI:https://doi.org/10.1074/jbc.M110.118976.
   PubMed Web of Science ®Google Scholar
• Jo C, Kim S, Cho SJ, et al. Sulforaphane induces autophagy through ERK activation in neuronal cells. FEBS Lett. 2014;588(17):3081–3088. DOI:https://doi.org/10.1016/j.febslet.2014.06.036.
   PubMed Web of Science ®Google Scholar
• Komatsu M, Kurokawa H, Waguri S, et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol. 2010;12(3):213–223. DOI:https://doi.org/10.1038/ncb2021.
   PubMed Web of Science ®Google Scholar
• Kuusisto E, Suuronen T, Salminen A. Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. Biochem Biophys Res Commun. 2001;280(1):223–228.
   PubMed Web of Science ®Google Scholar
• Zatloukal K, Stumptner C, Fuchsbichler A, et al. p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol. 2002;160(1):255–263. DOI:https://doi.org/10.1016/S0002-9440(10)64369-6.
   PubMed Web of Science ®Google Scholar
• Arai T, Nonaka T, Hasegawa M, et al. Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62. Neurosci Lett. 2003;342(1–2):41–44. DOI:https://doi.org/10.1016/S0304-3940(03)00216-7.
   PubMed Web of Science ®Google Scholar
• Hiji M, Takahashi T, Fukuba H, et al. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin. Acta Neuropathol. 2008;116(2):183–191. DOI:https://doi.org/10.1007/s00401-008-0402-2.
   PubMed Web of Science ®Google Scholar
• Mizuno Y, Amari M, Takatama M, et al. Immunoreactivities of p62, an ubiqutin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J Neurol Sci. 2006;249(1):13–18. DOI:https://doi.org/10.1016/j.jns.2006.05.060.
   PubMed Web of Science ®Google Scholar
• Al-Sarraj S, King A, Troakes C, et al. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol. 2011;122(6):691–702. DOI:https://doi.org/10.1007/s00401-011-0911-2.
   PubMed Web of Science ®Google Scholar
• Mackenzie IR, Frick P, Neumann M. The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol. 2014;127(3):347–357.
   PubMed Web of Science ®Google Scholar
• Troakes C, Maekawa S, Wijesekera L, et al. An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline. Neuropathology. 2012;32(5):505–514. DOI:https://doi.org/10.1111/j.1440-1789.2011.01286.x.
   PubMed Web of Science ®Google Scholar
• Türk M, Haaker G, Winter L, et al. C9ORF72-ALS: P62- and ubiquitin-aggregation pathology in skeletal muscle. Muscle Nerve. 2014;50(3):454–455. DOI:https://doi.org/10.1002/mus.24283.
   PubMed Web of Science ®Google Scholar
• Le Ber I, Camuzat A, Guerreiro R, et al. SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. JAMA Neurol. 2013;70(11):1403–1410. DOI:https://doi.org/10.1001/jamaneurol.2013.3849.
   PubMed Web of Science ®Google Scholar
• Fecto F, Yan J, Vemula SP, et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2011;68(11):1440–1446. DOI:https://doi.org/10.1001/archneurol.2011.250.
   PubMedGoogle Scholar
• Teyssou E, Takeda T, Lebon V, et al. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology. Acta Neuropathol. 2013;125(4):511–522.
   PubMed Web of Science ®Google Scholar
• Laurin N, Brown JP, Morissette J, et al. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet. 2002;70(6):1582–1588. DOI:https://doi.org/10.1086/340731.
   PubMed Web of Science ®Google Scholar
• Rea SL, Majcher V, Searle MS, et al. SQSTM1 mutations–bridging Paget disease of bone and ALS/FTLD. Exp Cell Res. 2014;325(1):27–37. DOI:https://doi.org/10.1016/j.yexcr.2014.01.020.
   PubMed Web of Science ®Google Scholar
• Gang Q, Bettencourt C, Machado PM, et al. Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis. Neurobiol Aging. 2016;47:218.e1–218.e9.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim NC, Wang YD, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495(7442):467–473. DOI:https://doi.org/10.1038/nature11922.
   PubMed Web of Science ®Google Scholar
• Rea SL, Walsh JP, Layfield R, et al. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget’s disease of bone. Endocr Rev. 2013;34(4):501–524.
   PubMed Web of Science ®Google Scholar
• Ichimura Y, Kumanomidou T, Sou YS, et al. Structural basis for sorting mechanism of p62 in selective autophagy. J Biol Chem. 2008;283(33):22847–22857. DOI:https://doi.org/10.1074/jbc.M802182200.
   PubMed Web of Science ®Google Scholar
• Du Y, Wooten MC, Wooten MW. Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease. Neurobiol Dis. 2009;35(2):302–310.
   PubMed Web of Science ®Google Scholar
• Rubino E, Rainero I, Chiò A, et al. SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology. 2012;79(15):1556–1562. DOI:https://doi.org/10.1212/WNL.0b013e31826e25df.
   PubMed Web of Science ®Google Scholar
• Babu A, Wang Q, Muralidharan R, et al. Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells. Mol Pharm. 2014;11(8):2720–2733. DOI:https://doi.org/10.1021/mp500259e.
   PubMed Web of Science ®Google Scholar
• Durán A, Serrano M, Leitges M, et al. The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev Cell. 2004;6(2):303–309. DOI:https://doi.org/10.1016/S1534-5807(03)00403-9.
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Durán A, Selloum M, et al. Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell Metab. 2006;3(3):211–222. DOI:https://doi.org/10.1016/j.cmet.2006.01.011.
   PubMed Web of Science ®Google Scholar
• Lattante S, De Calbiac H, Le Ber I, et al. Sqstm1 knock-down causes a locomotor phenotype ameliorated by rapamycin in a zebrafish model of ALS/FTLD. Hum Mol Genet. 2015;24(6):1682–1690. DOI:https://doi.org/10.1093/hmg/ddu580.
   PubMed Web of Science ®Google Scholar
• Daroszewska A, Van ‘T Hof RJ, Rojas JA, et al. A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget’s disease-like disorder in mice. Hum Mol Genet. 2011;20(14):2734–2744. DOI:https://doi.org/10.1093/hmg/ddr172.
   PubMed Web of Science ®Google Scholar
• Kurihara N, Hiruma Y, Zhou H, et al. Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. J Clin Invest. 2007;117(1):133–142. DOI:https://doi.org/10.1172/JCI28267.
   PubMed Web of Science ®Google Scholar
• Seibenhener ML, Zhao T, Du Y, et al. Behavioral effects of SQSTM1/p62 overexpression in mice: support for a mitochondrial role in depression and anxiety. Behav Brain Res. 2013;248:94–103.
   PubMed Web of Science ®Google Scholar
• DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245–256. DOI:https://doi.org/10.1016/j.neuron.2011.09.011.
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257–268. DOI:https://doi.org/10.1016/j.neuron.2011.09.010.
   PubMed Web of Science ®Google Scholar
• Levine TP, Daniels RD, Gatta AT, et al. The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs. Bioinformatics. 2013;29(4):499–503. DOI:https://doi.org/10.1093/bioinformatics/bts725.
   PubMed Web of Science ®Google Scholar
• Zhang D, Iyer LM, He F, et al. Discovery of Novel DENN Proteins: implications for the Evolution of Eukaryotic Intracellular Membrane Structures and Human Disease. Front Genet. 2012;3:283.
   PubMedGoogle Scholar
• Farg MA, Sundaramoorthy V, Sultana JM, et al. C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum Mol Genet. 2014;23(13):3579–3595. DOI:https://doi.org/10.1093/hmg/ddu068.
   PubMed Web of Science ®Google Scholar
• Almeida S, Gao FB. Lost & found: C9ORF72 and the autophagy pathway in ALS/FTD. Embo J. 2016;35(12):1251–1253.
   PubMed Web of Science ®Google Scholar
• Amick J, Tharkeshwar AK, Amaya C, et al. WDR41 supports lysosomal response to changes in amino acid availability. Mol Biol Cell. 2018;29(18):2213–2227. DOI:https://doi.org/10.1091/mbc.E17-12-0703.
   PubMed Web of Science ®Google Scholar
• Sellier C, Campanari ML, Julie Corbier C, et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. Embo J. 2016;35(12):1276–1297. DOI:https://doi.org/10.15252/embj.201593350.
   PubMed Web of Science ®Google Scholar
• Sullivan PM, Zhou X, Robins AM, et al. The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. Acta Neuropathol Commun. 2016;4(1):51. DOI:https://doi.org/10.1186/s40478-016-0324-5.
   PubMed Web of Science ®Google Scholar
• Yang M, Liang C, Swaminathan K, et al. A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci Adv. 2016;2(9):e1601167. DOI:https://doi.org/10.1126/sciadv.1601167.
   PubMed Web of Science ®Google Scholar
• Goud B, M M. Small GTP-binding proteins and their role in transport. Curr Opin Cell Biol. 1991;3(4):626–633.
   PubMedGoogle Scholar
• Thomas JD, Zhang YJ, Wei YH, et al. Rab1A is an mTORC1 activator and a colorectal oncogene. Cancer Cell. 2014;26(5):754–769. DOI:https://doi.org/10.1016/j.ccell.2014.09.008.
   PubMed Web of Science ®Google Scholar
• Webster CP, Smith EF, Bauer CS, et al. The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy. Embo J. 2016;35(15):1656–1676. DOI:https://doi.org/10.15252/embj.201694401.
   PubMed Web of Science ®Google Scholar
• Shi Y, Lin S, Staats KA, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med. 2018;24(3):313–325. DOI:https://doi.org/10.1038/nm.4490.
   PubMed Web of Science ®Google Scholar
• Anor CJ, Xi Z, Zhang M, et al. Mutation analysis of C9orf72 in patients with corticobasal syndrome. Neurobiol Aging. 2015;36(10):2905.e1–5. DOI:https://doi.org/10.1016/j.neurobiolaging.2015.06.008.
   Google Scholar
• Beck J, Poulter M, Hensman D, et al. Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am J Hum Genet. 2013;92(3):345–353. DOI:https://doi.org/10.1016/j.ajhg.2013.01.011.
   PubMed Web of Science ®Google Scholar
• Cacace R, Van Cauwenberghe C, Bettens K, et al. C9orf72 G4C2 repeat expansions in Alzheimer’s disease and mild cognitive impairment. Neurobiol Aging. 2013;34(6):1712.e1–7. DOI:https://doi.org/10.1016/j.neurobiolaging.2012.12.019.
   Google Scholar
• Harms M, Benitez BA, Cairns N, et al. C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease. JAMA Neurol. 2013;70(6):736–741. DOI:https://doi.org/10.1001/2013.jamaneurol.537.
   PubMed Web of Science ®Google Scholar
• Kostić VS, Dobričić V, Stanković I, et al. C9orf72 expansion as a possible genetic cause of Huntington disease phenocopy syndrome. J Neurol. 2014;261(10):1917–1921. DOI:https://doi.org/10.1007/s00415-014-7430-8.
   PubMed Web of Science ®Google Scholar
• Lesage S, Le Ber I, Condroyer C, et al. C9orf72 repeat expansions are a rare genetic cause of parkinsonism. Brain. 2013;136(2):385–391. DOI:https://doi.org/10.1093/brain/aws357.
   PubMed Web of Science ®Google Scholar
• Lindquist SG, Duno M, Batbayli M, et al. Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease. Clin Genet. 2013;83(3):279–283. DOI:https://doi.org/10.1111/j.1399-0004.2012.01903.x.
   PubMed Web of Science ®Google Scholar
• Luigetti M, Quaranta D, Conte A, et al. Frontotemporal dementia, Parkinsonism and lower motor neuron involvement in a patient with C9ORF72 expansion. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(1):66–69. DOI:https://doi.org/10.3109/17482968.2012.692383.
   PubMed Web of Science ®Google Scholar
• O’Dowd S, Curtin D, Waite AJ, et al. C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia also causes parkinsonism. Mov Disord. 2012;27(8):1072–1074. DOI:https://doi.org/10.1002/mds.25022.
   PubMed Web of Science ®Google Scholar
• Hensman Moss DJ, Poulter M, Beck J, et al. C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology. 2014;82(4):292–299. DOI:https://doi.org/10.1212/WNL.0000000000000061.
   PubMed Web of Science ®Google Scholar
• Ash PE, Bieniek KF, Gendron TF, et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. 2013;77(4):639–646. DOI:https://doi.org/10.1016/j.neuron.2013.02.004.
   PubMed Web of Science ®Google Scholar
• Kwon I, Xiang S, Kato M, et al. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science. 2014;345(6201):1139–1145. DOI:https://doi.org/10.1126/science.1254917.
   PubMed Web of Science ®Google Scholar
• Mori K, Arzberger T, Grässer FA, et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 2013;126(6):881–893. DOI:https://doi.org/10.1007/s00401-013-1189-3.
   PubMed Web of Science ®Google Scholar
• Wen X, Tan W, Westergard T, et al. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron. 2014;84(6):1213–1225. DOI:https://doi.org/10.1016/j.neuron.2014.12.010.
   PubMed Web of Science ®Google Scholar
• Mackenzie IR, Arzberger T, Kremmer E, et al. Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol. 2013;126(6):859–879. DOI:https://doi.org/10.1007/s00401-013-1181-y.
   PubMed Web of Science ®Google Scholar
• Mahoney CJ, Downey LE, Ridgway GR, et al. Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions. Alzheimers Res Ther. 2012;4(5):41. DOI:https://doi.org/10.1186/alzrt144.
   PubMed Web of Science ®Google Scholar
• Mann DM, Rollinson S, Robinson A, et al. Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72. Acta Neuropathol Commun. 2013;1(1):68. DOI:https://doi.org/10.1186/2051-5960-1-68
   PubMed Web of Science ®Google Scholar
• Boivin M, Pfister V, Gaucherot A, et al. Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. Embo J. 2020;39(4):e100574. DOI:https://doi.org/10.15252/embj.2018100574.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Jiang J, Gendron TF, et al. Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat Neurosci. 2020;23(5):615–624. DOI:https://doi.org/10.1038/s41593-020-0619-5.
   PubMed Web of Science ®Google Scholar
• Davidson Y, Robinson AC, Liu X, et al. Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins. Neuropathol Appl Neurobiol. 2016;42(3):242–254. DOI:https://doi.org/10.1111/nan.12292.
   PubMed Web of Science ®Google Scholar
• Gendron TF, Van Blitterswijk M, Bieniek KF, et al. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers. Acta Neuropathol. 2015;130(4):559–573. DOI:https://doi.org/10.1007/s00401-015-1474-4.
   PubMed Web of Science ®Google Scholar
• Gomez-Deza J, Lee YB, Troakes C, et al. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration. Acta Neuropathol Commun. 2015;3(1):38. DOI:https://doi.org/10.1186/s40478-015-0218-y.
   PubMed Web of Science ®Google Scholar
• Mackenzie IR, Frick P, Grässer FA, et al. Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol. 2015;130(6):845–861. DOI:https://doi.org/10.1007/s00401-015-1476-2.
   PubMed Web of Science ®Google Scholar
• Almeida S, Gascon E, Tran H, et al. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol. 2013;126(3):385–399. DOI:https://doi.org/10.1007/s00401-013-1149-y.
   PubMed Web of Science ®Google Scholar
• Ji YJ, Ugolino J, Brady NR, et al. Systemic deregulation of autophagy upon loss of ALS- and FTD-linked C9orf72. Autophagy. 2017;13(7):1254–1255. DOI:https://doi.org/10.1080/15548627.2017.1299312.
   PubMed Web of Science ®Google Scholar
• Ugolino J, Ji YJ, Conchina K, et al. Loss of C9orf72 Enhances Autophagic Activity via Deregulated mTOR and TFEB Signaling. PLoS Genet. 2016;12(11):e1006443. DOI:https://doi.org/10.1371/journal.pgen.1006443.
   PubMed Web of Science ®Google Scholar
• Madill M, McDonagh K, Ma J, et al. Amyotrophic lateral sclerosis patient iPSC-derived astrocytes impair autophagy via non-cell autonomous mechanisms. Mol Brain. 2017;10(1):22. DOI:https://doi.org/10.1186/s13041-017-0300-4.
   PubMed Web of Science ®Google Scholar
• Ciura S, Lattante S, Le Ber I, et al. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann Neurol. 2013;74(2):180–187. DOI:https://doi.org/10.1002/ana.23946.
   PubMed Web of Science ®Google Scholar
• Therrien M, Rouleau GA, Dion PA, et al. Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans. PLoS One. 2013;8(12):e83450. DOI:https://doi.org/10.1371/journal.pone.0083450.
   PubMed Web of Science ®Google Scholar
• Atanasio A, Decman V, White D, et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci Rep. 2016;6(1):23204. DOI:https://doi.org/10.1038/srep23204.
   PubMed Web of Science ®Google Scholar
• Burberry A, Suzuki N, Wang JY, et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci Transl Med. 2016;8(347):347ra93. DOI:https://doi.org/10.1126/scitranslmed.aaf6038.
   PubMed Web of Science ®Google Scholar
• O’Rourke JG, Bogdanik L, Muhammad A, et al. C9orf72 BAC transgenic mice display typical pathologic features of ALS/FTD. Neuron. 2015;88(5):892–901. DOI:https://doi.org/10.1016/j.neuron.2015.10.027.
   PubMed Web of Science ®Google Scholar
• Sudria-Lopez E, Koppers M, De Wit M, et al. Full ablation of C9orf72 in mice causes immune system-related pathology and neoplastic events but no motor neuron defects. Acta Neuropathol. 2016;132(1):145–147. DOI:https://doi.org/10.1007/s00401-016-1581-x.
   PubMed Web of Science ®Google Scholar
• Devlin AC, Burr K, Borooah S, et al. Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability. Nat Commun. 2015;6(1):5999. DOI:https://doi.org/10.1038/ncomms6999.
   PubMed Web of Science ®Google Scholar
• Wainger BJ, Kiskinis E, Mellin C, et al. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep. 2014;7(1):1–11. DOI:https://doi.org/10.1016/j.celrep.2014.03.019.
   PubMed Web of Science ®Google Scholar
• Donnelly CJ, Zhang PW, Pham JT, et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 2013;80(2):415–428. DOI:https://doi.org/10.1016/j.neuron.2013.10.015.
   PubMed Web of Science ®Google Scholar
• Selvaraj BT, Livesey MR, Zhao C, et al. C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca(2+)-permeable AMPA receptor-mediated excitotoxicity. Nat Commun. 2018;9(1):347. DOI:https://doi.org/10.1038/s41467-017-02729-0.
   PubMed Web of Science ®Google Scholar
• Oakes JA, Davies MC, Collins MO. TBK1: a new player in ALS linking autophagy and neuroinflammation. Mol Brain. 2017;10(1):5.
   PubMed Web of Science ®Google Scholar
• Uhlén M, Fagerberg L, Hallström BM, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.
   PubMed Web of Science ®Google Scholar
• Richter B, Sliter DA, Herhaus L, et al. Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc Natl Acad Sci U S A. 2016;113(15):4039–4044. DOI:https://doi.org/10.1073/pnas.1523926113.
   PubMed Web of Science ®Google Scholar
• Loo YM, Gale M Jr. Immune signaling by RIG-I-like receptors. Immunity. 2011;34(5):680–692.
   PubMed Web of Science ®Google Scholar
• Wild P, Farhan H, McEwan DG, et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science. 2011;333(6039):228–233. DOI:https://doi.org/10.1126/science.1205405.
   PubMed Web of Science ®Google Scholar
• Jung J, Nayak A, Schaeffer V, et al. Multiplex image-based autophagy RNAi screening identifies SMCR8 as ULK1 kinase activity and gene expression regulator. Elife. 2017;6:6.
   Web of Science ®Google Scholar
• Nakashima H, Nguyen T, Goins WF, et al. Interferon-stimulated gene 15 (ISG15) and ISG15-linked proteins can associate with members of the selective autophagic process, histone deacetylase 6 (HDAC6) and SQSTM1/p62. J Biol Chem. 2015;290(3):1485–1495. DOI:https://doi.org/10.1074/jbc.M114.593871.
   PubMed Web of Science ®Google Scholar
• Xu D, Zhang T, Xiao J, et al. Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferon. Autophagy. 2015;11(4):617–628. DOI:https://doi.org/10.1080/15548627.2015.1023982.
   PubMed Web of Science ®Google Scholar
• Goncalves A, Bürckstümmer T, Dixit E, et al. Functional dissection of the TBK1 molecular network. PLoS One. 2011;6(9):e23971. DOI:https://doi.org/10.1371/journal.pone.0023971.
   PubMed Web of Science ®Google Scholar
• Kim JY, Beg AA, Haura EB, et al. IKKϵ and TBK1, as novel therapeutic targets in the treatment of non-small cell lung cancer. Expert Opin Ther Targets. 2013;17(10):1109–1112.
   PubMed Web of Science ®Google Scholar
• Awadalla MS, Fingert JH, Roos BE, et al. Copy number variations of TBK1 in Australian patients with primary open-angle glaucoma. Am J Ophthalmol. 2015;159(1):124–30.e1. DOI:https://doi.org/10.1016/j.ajo.2014.09.044.
   PubMed Web of Science ®Google Scholar
• Ritch R, Darbro B, Menon G, et al. TBK1 gene duplication and normal-tension glaucoma. JAMA Ophthalmol. 2014;132(5):544–548. DOI:https://doi.org/10.1001/jamaophthalmol.2014.104.
   PubMed Web of Science ®Google Scholar
• Herman M, Ciancanelli M, Ou YH, et al. Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J Exp Med. 2012;209(9):1567–1582. DOI:https://doi.org/10.1084/jem.20111316.
   PubMed Web of Science ®Google Scholar
• Cirulli ET, Lasseigne BN, Petrovski S, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347(6229):1436–1441. DOI:https://doi.org/10.1126/science.aaa3650.
   PubMed Web of Science ®Google Scholar
• Freischmidt A, Wieland T, Richter B, et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci. 2015;18(5):631–636. DOI:https://doi.org/10.1038/nn.4000.
   PubMed Web of Science ®Google Scholar
• Gijselinck I, Van Mossevelde S, Van Der Zee J, et al. Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort. Neurology. 2015;85(24):2116–2125. DOI:https://doi.org/10.1212/WNL.0000000000002220.
   PubMed Web of Science ®Google Scholar
• Le Ber I, De Septenville A, Millecamps S, et al. TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts. Neurobiol Aging. 2015;36(11):3116.e5–3116.e8. DOI:https://doi.org/10.1016/j.neurobiolaging.2015.08.009.
   Google Scholar
• Pottier C, Bieniek KF, Finch N, et al. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol. 2015;130(1):77–92. DOI:https://doi.org/10.1007/s00401-015-1436-x.
   PubMed Web of Science ®Google Scholar
• Gijselinck I, Van Mossevelde S, Van Der Zee J, et al. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Mol Psychiatry. 2016;21(8):1112–1124. DOI:https://doi.org/10.1038/mp.2015.159.
   PubMed Web of Science ®Google Scholar
• Van Mossevelde S, Van Der Zee J, Gijselinck I, et al. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort. Brain. 2016;139(2):452–467. DOI:https://doi.org/10.1093/brain/awv358.
   PubMed Web of Science ®Google Scholar
• Lazarou M, Sliter DA, Kane LA, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524(7565):309–314. DOI:https://doi.org/10.1038/nature14893.
   PubMed Web of Science ®Google Scholar
• Moore AS, Holzbaur EL. Spatiotemporal dynamics of autophagy receptors in selective mitophagy. Autophagy. 2016;12(10):1956–1957.
   PubMed Web of Science ®Google Scholar
• Brenner D, Sieverding K, Bruno C, et al. Heterozygous Tbk1 loss has opposing effects in early and late stages of ALS in mice. J Exp Med. 2019;216(2):267–278.
   PubMed Web of Science ®Google Scholar
• Gerbino V, Kaunga E, Ye J, et al. The Loss of TBK1 Kinase Activity in Motor Neurons or in All Cell Types Differentially Impacts ALS Disease Progression in SOD1 Mice. Neuron. 2020;106(5):789–805.e5.
   PubMed Web of Science ®Google Scholar
• Yu J, Zhou X, Chang M, et al. Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation. Nat Commun. 2015;6(1):6074. DOI:https://doi.org/10.1038/ncomms7074.
   PubMed Web of Science ®Google Scholar
• Komine O, Yamanaka K. Neuroinflammation in motor neuron disease. Nagoya J Med Sci. 2015;77(4):537–549.
   PubMed Web of Science ®Google Scholar
• Walters KJ, Goh AM, Wang Q, et al. Ubiquitin family proteins and their relationship to the proteasome: a structural perspective. Biochim Biophys Acta. 2004;1695(1–3):73–87. DOI:https://doi.org/10.1016/j.bbamcr.2004.10.005.
   PubMed Web of Science ®Google Scholar
• N’Diaye EN, Kajihara KK, Hsieh I, et al. PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation. EMBO Rep. 2009;10(2):173–179. DOI:https://doi.org/10.1038/embor.2008.238.
   PubMed Web of Science ®Google Scholar
• Rothenberg C, Srinivasan D, Mah L, et al. Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. Hum Mol Genet. 2010;19(16):3219–3232. DOI:https://doi.org/10.1093/hmg/ddq231.
   PubMed Web of Science ®Google Scholar
• Deng HX, Chen W, Hong ST, et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477(7363):211–215. DOI:https://doi.org/10.1038/nature10353.
   PubMed Web of Science ®Google Scholar
• Millecamps S, Corcia P, Cazeneuve C, et al. Mutations in UBQLN2 are rare in French amyotrophic lateral sclerosis. Neurobiol Aging. 2012;33(4):839.e1–3. DOI:https://doi.org/10.1016/j.neurobiolaging.2011.11.010.
   Google Scholar
• Daoud H, Suhail H, Szuto A, et al. UBQLN2 mutations are rare in French and French-Canadian amyotrophic lateral sclerosis. Neurobiol Aging. 2012;33(9):2230.e1–2230.e5. DOI:https://doi.org/10.1016/j.neurobiolaging.2012.03.015.
   Google Scholar
• Mizusawa H, Nakamura H, Wakayama I, et al. Skein-like inclusions in the anterior horn cells in motor neuron disease. J Neurol Sci. 1991;105(1):14–21. DOI:https://doi.org/10.1016/0022-510X(91)90112-K.
   PubMed Web of Science ®Google Scholar
• Osaka M, Ito D, Suzuki N. Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2. Biochem Biophys Res Commun. 2016;472(2):324–331.
   PubMed Web of Science ®Google Scholar
• Ceballos-Diaz C, Rosario AM, Park HJ, et al. Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice. Mol Neurodegener. 2015;10(1):25. DOI:https://doi.org/10.1186/s13024-015-0026-7
   PubMed Web of Science ®Google Scholar
• Picher-Martel V, Dutta K, Phaneuf D, et al. Ubiquilin-2 drives NF-κB activity and cytosolic TDP-43 aggregation in neuronal cells. Mol Brain. 2015;8(1):71. DOI:https://doi.org/10.1186/s13041-015-0162-6.
   PubMed Web of Science ®Google Scholar
• Wu Q, Liu M, Huang C, et al. Pathogenic Ubqln2 gains toxic properties to induce neuron death. Acta Neuropathol. 2015;129(3):417–428. DOI:https://doi.org/10.1007/s00401-014-1367-y.
   PubMed Web of Science ®Google Scholar
• Şentürk M, Lin G, Zuo Z, et al. Ubiquilins regulate autophagic flux through mTOR signalling and lysosomal acidification. Nat Cell Biol. 2019;21(3):384–396. DOI:https://doi.org/10.1038/s41556-019-0281-x.
   PubMed Web of Science ®Google Scholar
• Wu JJ, Cai A, Greenslade JE, et al. ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function. Proc Natl Acad Sci U S A. 2020;117(26):15230–15241. DOI:https://doi.org/10.1073/pnas.1917371117.
   PubMed Web of Science ®Google Scholar
• Yang W, Hamilton JL, Kopil C, et al. Current and projected future economic burden of Parkinson’s disease in the U. S NPJ Parkinsons Dis. 2020;6(1):15. DOI:https://doi.org/10.1038/s41531-020-0117-1
   PubMed Web of Science ®Google Scholar
• Dormann D, Madl T, Valori CF, et al. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. Embo J. 2012;31(22):4258–4275. DOI:https://doi.org/10.1038/emboj.2012.261.
   PubMed Web of Science ®Google Scholar
• Huey ED, Ferrari R, Moreno JH, et al. FUS and TDP43 genetic variability in FTD and CBS. Neurobiol Aging. 2012;33(5):1016.e9–17. DOI:https://doi.org/10.1016/j.neurobiolaging.2011.08.004.
   Google Scholar
• Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79(3):416–438.
   PubMed Web of Science ®Google Scholar
• Ryu HH, Jun MH, Min KJ, et al. Autophagy regulates amyotrophic lateral sclerosis-linked fused in sarcoma-positive stress granules in neurons. Neurobiol Aging. 2014;35(12):2822–2831. DOI:https://doi.org/10.1016/j.neurobiolaging.2014.07.026.
   PubMed Web of Science ®Google Scholar
• Marrone L, Poser I, Casci I, et al. Isogenic FUS-eGFP iPSC reporter lines enable quantification of FUS stress granule pathology that is rescued by drugs inducing autophagy. Stem Cell Reports. 2018;10(2):375–389. DOI:https://doi.org/10.1016/j.stemcr.2017.12.018.
   PubMed Web of Science ®Google Scholar
• Arenas A, Kuang L, Zhang J, et al. FUS regulates autophagy by mediating the transcription of genes critical to the autophagosome formation. J Neurochem. 2020;157(3):752–763.
   Web of Science ®Google Scholar
• Halawani D, Latterich M. p97: the cell’s molecular purgatory?. Mol Cell. 2006;22(6):713–717.
   PubMed Web of Science ®Google Scholar
• Kakizuka A. Roles of VCP in human neurodegenerative disorders. Biochem Soc Trans. 2008;36(1):105–108.
   PubMed Web of Science ®Google Scholar
• Watts GD, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36(4):377–381. DOI:https://doi.org/10.1038/ng1332.
   PubMed Web of Science ®Google Scholar
• DeJesus-Hernandez M, Desaro P, Johnston A, et al. Novel p.Ile151Val mutation in VCP in a patient of African American descent with sporadic ALS. Neurology. 2011;77(11):1102–1103.
   PubMed Web of Science ®Google Scholar
• Koppers M, Groen EJ, Van Vught PW, et al. Screening for rare variants in the coding region of ALS-associated genes at 9p21.2 and 19p13.3. Neurobiol Aging. 2013;34(5):1518.e5–7. DOI:https://doi.org/10.1016/j.neurobiolaging.2012.09.018.
   Google Scholar
• Johnson JO, Mandrioli J, Benatar M, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68(5):857–864. DOI:https://doi.org/10.1016/j.neuron.2010.11.036.
   PubMed Web of Science ®Google Scholar
• Custer SK, Neumann M, Lu H, et al. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. Hum Mol Genet. 2010;19(9):1741–1755. DOI:https://doi.org/10.1093/hmg/ddq050.
   PubMed Web of Science ®Google Scholar
• Hübbers CU, Clemen CS, Kesper K, et al. Pathological consequences of VCP mutations on human striated muscle. Brain. 2007;130(2):381–393. DOI:https://doi.org/10.1093/brain/awl238.
   PubMed Web of Science ®Google Scholar
• Ju JS, Fuentealba RA, Miller SE, et al. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J Cell Biol. 2009;187(6):875–888. DOI:https://doi.org/10.1083/jcb.200908115.
   PubMed Web of Science ®Google Scholar
• Schröder R, Watts GD, Mehta SG, et al. Mutant valosin-containing protein causes a novel type of frontotemporal dementia. Ann Neurol. 2005;57(3):457–461. DOI:https://doi.org/10.1002/ana.20407.
   PubMed Web of Science ®Google Scholar
• Nalbandian A, Llewellyn KJ, Kitazawa M, et al. The homozygote VCP(R155H/R155H) mouse model exhibits accelerated human VCP-associated disease pathology. PLoS One. 2012;7(9):e46308.
   PubMed Web of Science ®Google Scholar
• Tresse E, Salomons FA, Vesa J, et al. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy. 2010;6(2):217–227. DOI:https://doi.org/10.4161/auto.6.2.11014.
   PubMed Web of Science ®Google Scholar
• Nalbandian A, Nguyen C, Katheria V, et al. Exercise training reverses skeletal muscle atrophy in an experimental model of VCP disease. PLoS One. 2013;8(10):e76187. DOI:https://doi.org/10.1371/journal.pone.0076187.
   PubMed Web of Science ®Google Scholar
• Yin HZ, Nalbandian A, Hsu CI, et al. Slow development of ALS-like spinal cord pathology in mutant valosin-containing protein gene knock-in mice. Cell Death Dis. 2012;3(8):e374. DOI:https://doi.org/10.1038/cddis.2012.115.
   PubMed Web of Science ®Google Scholar
• Hall CE, Yao Z, Choi M, et al. Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS. Cell Rep. 2017;19(9):1739–1749. DOI:https://doi.org/10.1016/j.celrep.2017.05.024.
   PubMed Web of Science ®Google Scholar
• Kachaner D, Génin P, Laplantine E, et al. Toward an integrative view of Optineurin functions. Cell Cycle. 2012;11(15):2808–2818. DOI:https://doi.org/10.4161/cc.20946.
   PubMed Web of Science ®Google Scholar
• Korac J, Schaeffer V, Kovacevic I, et al. Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J Cell Sci. 2013;126(2):580–592. DOI:https://doi.org/10.1242/jcs.114926.
   PubMed Web of Science ®Google Scholar
• Stolz A, Ernst A, Dikic I. Cargo recognition and trafficking in selective autophagy. Nat Cell Biol. 2014;16(6):495–501.
   PubMed Web of Science ®Google Scholar
• Wong YC, Holzbaur EL. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc Natl Acad Sci U S A. 2014;111(42):E4439–48.
   PubMed Web of Science ®Google Scholar
• Liu Z, Chen P, Gao H, et al. Ubiquitylation of autophagy receptor optineurin by HACE1 activates selective autophagy for tumor suppression. Cancer Cell. 2014;26(1):106–120. DOI:https://doi.org/10.1016/j.ccr.2014.05.015.
   PubMed Web of Science ®Google Scholar
• Maruyama H, Morino H, Ito H, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465(7295):223–226. DOI:https://doi.org/10.1038/nature08971.
   PubMed Web of Science ®Google Scholar
• Evans CS, Holzbaur EL. Degradation of engulfed mitochondria is rate-limiting in Optineurin-mediated mitophagy in neurons. Elife. 2020;9:9.
   Web of Science ®Google Scholar
• Sako W, Ito H, Yoshida M, et al. Nuclear factor κ B expression in patients with sporadic amyotrophic lateral sclerosis and hereditary amyotrophic lateral sclerosis with optineurin mutations. Clin Neuropathol. 2012;31(6):418–423. DOI:https://doi.org/10.5414/NP300493.
   PubMed Web of Science ®Google Scholar
• Akizuki M, Yamashita H, Uemura K, et al. Optineurin suppression causes neuronal cell death via NF-κB pathway. J Neurochem. 2013;126(6):699–704. DOI:https://doi.org/10.1111/jnc.12326.
   PubMed Web of Science ®Google Scholar
• Ghazi-Tabatabai S, Obita T, Pobbati AV, et al. Evolution and assembly of ESCRTs. Biochem Soc Trans. 2009;37(1):151–155. DOI:https://doi.org/10.1042/BST0370151.
   PubMed Web of Science ®Google Scholar
• Odorizzi G. Membrane manipulations by the ESCRT machinery. F1000Res. 2015;4(F1000 Faculty Rev):516.
   PubMedGoogle Scholar
• Skibinski G, Parkinson NJ, Brown JM, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet. 2005;37(8):806–808. DOI:https://doi.org/10.1038/ng1609.
   PubMed Web of Science ®Google Scholar
• Van Der Zee J, Urwin H, Engelborghs S, et al. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum Mol Genet. 2008;17(2):313–322. DOI:https://doi.org/10.1093/hmg/ddm309.
   PubMed Web of Science ®Google Scholar
• Cox LE, Ferraiuolo L, Goodall EF, et al. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS One. 2010;5(3):e9872. DOI:https://doi.org/10.1371/journal.pone.0009872.
   PubMed Web of Science ®Google Scholar
• Parkinson N, Ince PG, Smith MO, et al. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology. 2006;67(6):1074–1077. DOI:https://doi.org/10.1212/01.wnl.0000231510.89311.8b.
   PubMed Web of Science ®Google Scholar
• Filimonenko M, Stuffers S, Raiborg C, et al. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J Cell Biol. 2007;179(3):485–500. DOI:https://doi.org/10.1083/jcb.200702115.
   PubMed Web of Science ®Google Scholar
• Lee JA, Beigneux A, Ahmad ST, et al. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. Curr Biol. 2007;17(18):1561–1567. DOI:https://doi.org/10.1016/j.cub.2007.07.029.
   PubMed Web of Science ®Google Scholar
• Clayton EL, Mancuso R, Nielsen TT, et al. Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation. Hum Mol Genet. 2017;26(5):873–887. DOI:https://doi.org/10.1093/hmg/ddx003.
   PubMed Web of Science ®Google Scholar
• Ghazi-Noori S, Froud KE, Mizielinska S, et al. Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice. Brain. 2012;135(3):819–832. DOI:https://doi.org/10.1093/brain/aws006.
   PubMed Web of Science ®Google Scholar
• Clayton EL, Mizielinska S, Edgar JR, et al. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology. Acta Neuropathol. 2015;130(4):511–523. DOI:https://doi.org/10.1007/s00401-015-1475-3.
   PubMed Web of Science ®Google Scholar
• Sasaki S. Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2011;70(5):349–359.
   PubMed Web of Science ®Google Scholar
• Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351(3):602–611. DOI:https://doi.org/10.1016/j.bbrc.2006.10.093.
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130–133. DOI:https://doi.org/10.1126/science.1134108.
   PubMed Web of Science ®Google Scholar
• Ying Z, Xia Q, Hao Z, et al. TARDBP/TDP-43 regulates autophagy in both MTORC1-dependent and MTORC1-independent manners. Autophagy. 2016;12(4):707–708. DOI:https://doi.org/10.1080/15548627.2016.1151596.
   PubMed Web of Science ®Google Scholar
• Ito Y, Yamada M, Tanaka H, et al. Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice. Neurobiol Dis. 2009;36(3):470–476. DOI:https://doi.org/10.1016/j.nbd.2009.08.013.
   PubMed Web of Science ®Google Scholar
• Atkin JD, Farg MA, Walker AK, et al. Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis. Neurobiol Dis. 2008;30(3):400–407. DOI:https://doi.org/10.1016/j.nbd.2008.02.009.
   PubMed Web of Science ®Google Scholar
• Sasaki S. Endoplasmic reticulum stress in motor neurons of the spinal cord in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2010;69(4):346–355.
   PubMed Web of Science ®Google Scholar
• Ilieva EV, Ayala V, Jové M, et al. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain. 2007;130(Pt 12):3111–3123. DOI:https://doi.org/10.1093/brain/awm190.
   PubMed Web of Science ®Google Scholar
• Atsumi T. The ultrastructure of intramuscular nerves in amyotrophic lateral sclerosis. Acta Neuropathol. 1981;55(3):193–198.
   PubMed Web of Science ®Google Scholar
• Chung MJ, Suh YL. Ultrastructural changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis. Ultrastruct Pathol. 2002;26(1):3–7.
   PubMed Web of Science ®Google Scholar
• Napoli L, Crugnola V, Lamperti C, et al. Ultrastructural mitochondrial abnormalities in patients with sporadic amyotrophic lateral sclerosis. Arch Neurol. 2011;68(12):1612–1613. DOI:https://doi.org/10.1001/archneur.68.12.1612.
   PubMedGoogle Scholar
• Sasaki S, Iwata M. Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis. Neurosci Lett. 1996;204(1–2):53–56.
   PubMed Web of Science ®Google Scholar
• Wiedemann FR, Winkler K, Kuznetsov AV, et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci. 1998;156(1):65–72. DOI:https://doi.org/10.1016/S0022-510X(98)00008-2.
   PubMed Web of Science ®Google Scholar
• Deng HX, Bigio EH, Zhai H, et al. Differential involvement of optineurin in amyotrophic lateral sclerosis with or without SOD1 mutations. Arch Neurol. 2011;68(8):1057–1061. DOI:https://doi.org/10.1001/archneurol.2011.178.
   PubMedGoogle Scholar
• Li C, Ji Y, Tang L, et al. Optineurin mutations in patients with sporadic amyotrophic lateral sclerosis in China. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7–8):485–489. DOI:https://doi.org/10.3109/21678421.2015.1089909.
   PubMed Web of Science ®Google Scholar
• Toth RP, Atkin JD. Dysfunction of optineurin in amyotrophic lateral sclerosis and glaucoma. Front Immunol. 2018;9:1017.
   PubMed Web of Science ®Google Scholar
• Yang L, Cheng Y, Jia X, et al. Four novel optineurin mutations in patients with sporadic amyotrophic lateral sclerosis in Mainland China. Neurobiol Aging. 2021;97:149.e1–149.e8.
   Web of Science ®Google Scholar
• Kabashi E, Valdmanis PN, Dion P, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40(5):572–574. DOI:https://doi.org/10.1038/ng.132.
   PubMed Web of Science ®Google Scholar
• Sreedharan J, Blair IP, Tripathi VB, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319(5870):1668–1672. DOI:https://doi.org/10.1126/science.1154584.
   PubMed Web of Science ®Google Scholar
• Van Deerlin VM, Leverenz JB, Bekris LM, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008;7(5):409–416. DOI:https://doi.org/10.1016/S1474-4422(08)70071-1.
   PubMed Web of Science ®Google Scholar
• Yokoseki A, Shiga A, Tan CF, et al. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol. 2008;63(4):538–542. DOI:https://doi.org/10.1002/ana.21392.
   PubMed Web of Science ®Google Scholar
• Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362(6415):59–62. DOI:https://doi.org/10.1038/362059a0.
   PubMed Web of Science ®Google Scholar
• Sea K, Sohn SH, Durazo A, et al. Insights into the role of the unusual disulfide bond in copper-zinc superoxide dismutase. J Biol Chem. 2015;290(4):2405–2418. DOI:https://doi.org/10.1074/jbc.M114.588798.
   PubMed Web of Science ®Google Scholar
• Zou ZY, Zhou ZR, Che CH, et al. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88(7):540–549. DOI:https://doi.org/10.1136/jnnp-2016-315018.
   PubMed Web of Science ®Google Scholar
• Barmada SJ, Skibinski G, Korb E, et al. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci. 2010;30(2):639–649. DOI:https://doi.org/10.1523/JNEUROSCI.4988-09.2010.
   PubMed Web of Science ®Google Scholar
• Bilican B, Serio A, Barmada SJ, et al. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci U S A. 2012;109(15):5803–5808. DOI:https://doi.org/10.1073/pnas.1202922109.
   PubMed Web of Science ®Google Scholar
• Serio A, Bilican B, Barmada SJ, et al. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc Natl Acad Sci U S A. 2013;110(12):4697–4702. DOI:https://doi.org/10.1073/pnas.1300398110.
   PubMed Web of Science ®Google Scholar
• Huang SL, Wu LS, Lee M, et al. A robust TDP-43 knock-in mouse model of ALS. Acta Neuropathol Commun. 2020;8(1):3. DOI:https://doi.org/10.1186/s40478-020-0881-5.
   PubMed Web of Science ®Google Scholar
• Stallings NR, Puttaparthi K, Luther CM, et al. Progressive motor weakness in transgenic mice expressing human TDP-43. Neurobiol Dis. 2010;40(2):404–414. DOI:https://doi.org/10.1016/j.nbd.2010.06.017.
   PubMed Web of Science ®Google Scholar
• Xu YF, Gendron TF, Zhang YJ, et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci. 2010;30(32):10851–10859. DOI:https://doi.org/10.1523/JNEUROSCI.1630-10.2010.
   PubMed Web of Science ®Google Scholar
• Wils H, Kleinberger G, Janssens J, et al. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A. 2010;107(8):3858–3863. DOI:https://doi.org/10.1073/pnas.0912417107.
   PubMed Web of Science ®Google Scholar
• Shan X, Chiang PM, Price DL, et al. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc Natl Acad Sci U S A. 2010;107(37):16325–16330. DOI:https://doi.org/10.1073/pnas.1003459107.
   PubMed Web of Science ®Google Scholar
• Tsai KJ, Yang CH, Fang YH, et al. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. J Exp Med. 2010;207(8):1661–1673. DOI:https://doi.org/10.1084/jem.20092164.
   PubMed Web of Science ®Google Scholar
• Igaz LM, Kwong LK, Lee EB, et al. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J Clin Invest. 2011;121(2):726–738. DOI:https://doi.org/10.1172/JCI44867.
   PubMed Web of Science ®Google Scholar
• Tian T, Huang C, Tong J, et al. TDP-43 potentiates alpha-synuclein toxicity to dopaminergic neurons in transgenic mice. Int J Biol Sci. 2011;7(2):234–243. DOI:https://doi.org/10.7150/ijbs.7.234.
   PubMed Web of Science ®Google Scholar
• Swarup V, Phaneuf D, Bareil C, et al. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain. 2011;134(9):2610–2626. DOI:https://doi.org/10.1093/brain/awr159.
   PubMed Web of Science ®Google Scholar
• Cannon A, Yang B, Knight J, et al. Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction. Acta Neuropathol. 2012;123(6):807–823.
   PubMed Web of Science ®Google Scholar
• Arnold ES, Ling SC, Huelga SC, et al. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci U S A. 2013;110(8):E736–45. DOI:https://doi.org/10.1073/pnas.1222809110.
   PubMed Web of Science ®Google Scholar
• Zhou H, Huang C, Chen H, et al. Transgenic rat model of neurodegeneration caused by mutation in the TDP gene. PLoS Genet. 2010;6(3):e1000887. DOI:https://doi.org/10.1371/journal.pgen.1000887.
   PubMed Web of Science ®Google Scholar
• Uchida A, Sasaguri H, Kimura N, et al. Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43. Brain. 2012;135(3):833–846. DOI:https://doi.org/10.1093/brain/awr348.
   PubMed Web of Science ®Google Scholar
• Dayton RD, Wang DB, Cain CD, et al. Frontotemporal lobar degeneration-related proteins induce only subtle memory-related deficits when bilaterally overexpressed in the dorsal hippocampus. Exp Neurol. 2012;233(2):807–814. DOI:https://doi.org/10.1016/j.expneurol.2011.12.002.
   PubMed Web of Science ®Google Scholar
• Herman AM, Khandelwal PJ, Rebeck GW, et al. Wild type TDP-43 induces neuro-inflammation and alters APP metabolism in lentiviral gene transfer models. Exp Neurol. 2012;235(1):297–305. DOI:https://doi.org/10.1016/j.expneurol.2012.02.011.
   PubMed Web of Science ®Google Scholar
• Tatom JB, Wang DB, Dayton RD, et al. Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig’s disease in rats via TDP-43 overexpression. Mol Ther. 2009;17(4):607–613. DOI:https://doi.org/10.1038/mt.2009.3.
   PubMed Web of Science ®Google Scholar
• Wang DB, Dayton RD, Henning PP, et al. Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed. Mol Ther. 2010;18(12):2064–2074. DOI:https://doi.org/10.1038/mt.2010.191.
   PubMed Web of Science ®Google Scholar
• Dayton RD, Gitcho MA, Orchard EA, et al. Selective forelimb impairment in rats expressing a pathological TDP-43 25 kDa C-terminal fragment to mimic amyotrophic lateral sclerosis. Mol Ther. 2013;21(7):1324–1334. DOI:https://doi.org/10.1038/mt.2013.88.
   PubMed Web of Science ®Google Scholar
• Caccamo A, Majumder S, Oddo S. Cognitive decline typical of frontotemporal lobar degeneration in transgenic mice expressing the 25-kDa C-terminal fragment of TDP-43. Am J Pathol. 2012;180(1):293–302.
   PubMed Web of Science ®Google Scholar
• Wegorzewska I, Bell S, Cairns NJ, et al. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A. 2009;106(44):18809–18814. DOI:https://doi.org/10.1073/pnas.0908767106.
   PubMed Web of Science ®Google Scholar
• Xu YF, Zhang YJ, Lin WL, et al. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice. Mol Neurodegener. 2011;6(1):73. DOI:https://doi.org/10.1186/1750-1326-6-73
   PubMed Web of Science ®Google Scholar
• Janssens J, Wils H, Kleinberger G, et al. Overexpression of ALS-associated p.M337V human TDP-43 in mice worsens disease features compared to wild-type human TDP-43 mice. Mol Neurobiol. 2013;48(1):22–35.
   PubMed Web of Science ®Google Scholar
• Huang C, Tong J, Bi F, et al. Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats. J Clin Invest. 2012;122(1):107–118. DOI:https://doi.org/10.1172/JCI59130.
   PubMed Web of Science ®Google Scholar
• Chiang PM, Ling J, Jeong YH, et al. Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc Natl Acad Sci U S A. 2010;107(37):16320–16324. DOI:https://doi.org/10.1073/pnas.1002176107.
   PubMed Web of Science ®Google Scholar
• Iguchi Y, Katsuno M, Niwa J, et al. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain. 2013;136(5):1371–1382. DOI:https://doi.org/10.1093/brain/awt029.
   PubMed Web of Science ®Google Scholar
• Kraemer BC, Schuck T, Wheeler JM, et al. Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol. 2010;119(4):409–419. DOI:https://doi.org/10.1007/s00401-010-0659-0.
   PubMed Web of Science ®Google Scholar
• Sephton CF, Good SK, Atkin S, et al. TDP-43 is a developmentally regulated protein essential for early embryonic development. J Biol Chem. 2010;285(9):6826–6834. DOI:https://doi.org/10.1074/jbc.M109.061846.
   PubMed Web of Science ®Google Scholar
• Wu LS, Cheng WC, Hou SC, et al. TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis. 2010;48(1):56–62. DOI:https://doi.org/10.1002/dvg.20584.
   PubMed Web of Science ®Google Scholar
• Wu LS, Cheng WC, Shen CK. Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice. J Biol Chem. 2012;287(33):27335–27344.
   PubMed Web of Science ®Google Scholar
• Wegorzewska I, Baloh RHTDP. 43-based animal models of neurodegeneration: new insights into ALS pathology and pathophysiology. Neurodegener Dis. 2011;8(4):262–274.
   PubMed Web of Science ®Google Scholar
• Baralle M, Buratti E, Baralle FE. The role of TDP-43 in the pathogenesis of ALS and FTLD. Biochem Soc Trans. 2013;41(6):1536–1540.
   PubMed Web of Science ®Google Scholar
• Casci I, Pandey UB. A fruitful endeavor: modeling ALS in the fruit fly. Brain Res. 2015;1607:47–74.
   PubMed Web of Science ®Google Scholar
• Chen H, Kankel MW, Su SC, et al. Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD. Cell Death Differ. 2018;25(4):648–662. DOI:https://doi.org/10.1038/s41418-018-0060-4.
   PubMed Web of Science ®Google Scholar
• Liu YC, Chiang PM, Tsai KJ. Disease animal models of TDP-43 proteinopathy and their pre-clinical applications. Int J Mol Sci. 2013;14(10):20079–20111.
   PubMed Web of Science ®Google Scholar
• Tan RH, Ke YD, Ittner LM, et al. ALS/FTLD: experimental models and reality. Acta Neuropathol. 2017;133(2):177–196. DOI:https://doi.org/10.1007/s00401-016-1666-6.
   PubMed Web of Science ®Google Scholar
• Hetz C, Thielen P, Matus S, et al. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev. 2009;23(19):2294–2306. DOI:https://doi.org/10.1101/gad.1830709.
   PubMed Web of Science ®Google Scholar
• Rudnick ND, Griffey CJ, Guarnieri P, et al. Distinct roles for motor neuron autophagy early and late in the SOD1(G93A) mouse model of ALS. Proc Natl Acad Sci U S A. 2017;114(39):E8294–e8303. DOI:https://doi.org/10.1073/pnas.1704294114.
   PubMed Web of Science ®Google Scholar
• Morimoto N, Nagai M, Ohta Y, et al. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res. 2007;1167:112–117.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li L, Chen S, et al. Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Autophagy. 2011;7(4):412–425. DOI:https://doi.org/10.4161/auto.7.4.14541.
   PubMed Web of Science ®Google Scholar
• Gong YH, Parsadanian AS, Andreeva A, et al. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J Neurosci. 2000;20(2):660–665. DOI:https://doi.org/10.1523/JNEUROSCI.20-02-00660.2000.
   PubMed Web of Science ®Google Scholar
• Vargas MR, Johnson DA, Sirkis DW, et al. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci. 2008;28(50):13574–13581. DOI:https://doi.org/10.1523/JNEUROSCI.4099-08.2008.
   PubMed Web of Science ®Google Scholar
• Julien JP, Kriz J. Transgenic mouse models of amyotrophic lateral sclerosis. Biochim Biophys Acta. 2006;1762(11–12):1013–1024.
   PubMed Web of Science ®Google Scholar
• Morrice JR, Gregory-Evans CY, Shaw CA. Animal models of amyotrophic lateral sclerosis: a comparison of model validity. Neural Regen Res. 2018;13(12):2050–2054.
   PubMed Web of Science ®Google Scholar
• Philips T, Rothstein JD. Rodent models of amyotrophic lateral sclerosis. Curr Protoc Pharmacol. 2015;69(1):5.67.1–5.67.21.
   PubMedGoogle Scholar
• Van Damme P, Robberecht W, Van Den Bosch L. and Van Den Bosch L. Modelling amyotrophic lateral sclerosis: progress and possibilities. Dis Model Mech. 2017;10(5):537–549.
   PubMed Web of Science ®Google Scholar
• Nishihira Y, Tan CF, Onodera O, et al. Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol. 2008;116(2):169–182. DOI:https://doi.org/10.1007/s00401-008-0385-z.
   PubMed Web of Science ®Google Scholar
• Zhang H, Tan CF, Mori F, et al. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 2008;115(1):115–122. DOI:https://doi.org/10.1007/s00401-007-0285-7.
   PubMed Web of Science ®Google Scholar
• Papadeas ST, Kraig SE, O’Banion C, et al. Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo. Proc Natl Acad Sci U S A. 2011;108(43):17803–17808. DOI:https://doi.org/10.1073/pnas.1103141108.
   PubMed Web of Science ®Google Scholar
• Lepore AC, Rauck B, Dejea C, et al. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci. 2008;11(11):1294–1301. DOI:https://doi.org/10.1038/nn.2210.
   PubMed Web of Science ®Google Scholar
• Bose JK, Huang CC, Shen CK. Regulation of autophagy by neuropathological protein TDP-43. J Biol Chem. 2011;286(52):44441–44448.
   PubMed Web of Science ®Google Scholar
• Xia Q, Wang H, Hao Z, et al. TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion. Embo J. 2016;35(2):121–142. DOI:https://doi.org/10.15252/embj.201591998.
   PubMed Web of Science ®Google Scholar
• Caccamo A, Shaw DM, Guarino F, et al. Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43. Hum Mol Genet. 2015;24(16):4625–4635. DOI:https://doi.org/10.1093/hmg/ddv193.
   PubMed Web of Science ®Google Scholar
• Caccamo A, Majumder S, Deng JJ, et al. Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability. J Biol Chem. 2009;284(40):27416–27424. DOI:https://doi.org/10.1074/jbc.M109.031278.
   PubMed Web of Science ®Google Scholar
• Wang IF, Guo BS, Liu YC, et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc Natl Acad Sci U S A. 2012;109(37):15024–15029. DOI:https://doi.org/10.1073/pnas.1206362109.
   PubMed Web of Science ®Google Scholar
• Jinwal UK, Abisambra JF, Zhang J, et al. Cdc37/Hsp90 protein complex disruption triggers an autophagic clearance cascade for TDP-43 protein. J Biol Chem. 2012;287(29):24814–24820. DOI:https://doi.org/10.1074/jbc.M112.367268.
   PubMed Web of Science ®Google Scholar
• Crippa V, Carra S, Rusmini P, et al. A role of small heat shock protein B8 (HspB8) in the autophagic removal of misfolded proteins responsible for neurodegenerative diseases. Autophagy. 2010;6(7):958–960. DOI:https://doi.org/10.4161/auto.6.7.13042.
   PubMed Web of Science ®Google Scholar
• Crippa V, D’Agostino VG, Cristofani R, et al. Transcriptional induction of the heat shock protein B8 mediates the clearance of misfolded proteins responsible for motor neuron diseases. Sci Rep. 2016;6(1):22827. DOI:https://doi.org/10.1038/srep22827.
   PubMed Web of Science ®Google Scholar
• Barmada SJ, Serio A, Arjun A, et al. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat Chem Biol. 2014;10(8):677–685. DOI:https://doi.org/10.1038/nchembio.1563.
   PubMed Web of Science ®Google Scholar
• Urushitani M, Sato T, Bamba H, et al. Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP-43. J Neurosci Res. 2010;88(4):784–797. DOI:https://doi.org/10.1002/jnr.22243.
   PubMed Web of Science ®Google Scholar
• Wang X, Fan H, Ying Z, et al. Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system. Neurosci Lett. 2010;469(1):112–116. DOI:https://doi.org/10.1016/j.neulet.2009.11.055.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang H, Ying Z, et al. Ibudilast enhances the clearance of SOD1 and TDP-43 aggregates through TFEB-mediated autophagy and lysosomal biogenesis: the new molecular mechanism of ibudilast and its implication for neuroprotective therapy. Biochem Biophys Res Commun. 2020;526(1):231–238. DOI:https://doi.org/10.1016/j.bbrc.2020.03.051.
   PubMed Web of Science ®Google Scholar
• Natale G, Lenzi P, Lazzeri G, et al. Compartment-dependent mitochondrial alterations in experimental ALS, the effects of mitophagy and mitochondriogenesis. Front Cell Neurosci. 2015;9:434.
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu H, Guan Y, et al. The altered autophagy mediated by TFEB in animal and cell models of amyotrophic lateral sclerosis. Am J Transl Res. 2015;7(9):1574–1587.
   PubMed Web of Science ®Google Scholar
• Guo X, Sun X, Hu D, et al. VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington’s disease. Nat Commun. 2016;7(1):12646. DOI:https://doi.org/10.1038/ncomms12646.
   PubMed Web of Science ®Google Scholar
• Forloni G, Artuso V, La Vitola P, et al. Oligomeropathies and pathogenesis of Alzheimer and Parkinson’s diseases. Mov Disord. 2016;31(6):771–781. DOI:https://doi.org/10.1002/mds.26624.
   PubMed Web of Science ®Google Scholar
• Corcia P, Couratier P, Blasco H, et al. Genetics of amyotrophic lateral sclerosis. Rev Neurol (Paris). 2017;173(5):254–262. DOI:https://doi.org/10.1016/j.neurol.2017.03.030.
   PubMed Web of Science ®Google Scholar
• Redler RL, Dokholyan NV. The complex molecular biology of amyotrophic lateral sclerosis (ALS). Prog Mol Biol Transl Sci. 2012;107:215–262.
   PubMed Web of Science ®Google Scholar
• Bucelli RC, Arhzaouy K, Pestronk A, et al. SQSTM1 splice site mutation in distal myopathy with rimmed vacuoles. Neurology. 2015;85(8):665–674. DOI:https://doi.org/10.1212/WNL.0000000000001864.
   PubMed Web of Science ®Google Scholar
• Manley S, Williams JA, Ding WX. Role of p62/SQSTM1 in liver physiology and pathogenesis. Exp Biol Med (Maywood). 2013;238(5):525–538.
   PubMed Web of Science ®Google Scholar
• Lodish HF, Berk A, Zipursky SL, et al. Molecular Cell Biology. New York: W.H. Freeman; 2000. 1084.
   Google Scholar
• Maday S, Holzbaur EL. Compartment-Specific Regulation of Autophagy in Primary Neurons. J Neurosci. 2016;36(22):5933–5945.
   PubMed Web of Science ®Google Scholar
• Horgusluoglu E, Nudelman K, Nho K, et al. Adult neurogenesis and neurodegenerative diseases: a systems biology perspective. Am J Med Genet B Neuropsychiatr Genet. 2017;174(1):93–112. DOI:https://doi.org/10.1002/ajmg.b.32429.
   PubMed Web of Science ®Google Scholar
• Maday S, Wallace KE, Holzbaur EL. Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons. J Cell Biol. 2012;196(4):407–417.
   PubMed Web of Science ®Google Scholar
• Maday S, Holzbaur EL. Autophagosome biogenesis in primary neurons follows an ordered and spatially regulated pathway. Dev Cell. 2014;30(1):71–85.
   PubMed Web of Science ®Google Scholar
• Maday S, Holzbaur EL. Autophagosome assembly and cargo capture in the distal axon. Autophagy. 2012;8(5):858–860.
   PubMed Web of Science ®Google Scholar
• Wang QJ, Ding Y, Kohtz DS, et al. Induction of autophagy in axonal dystrophy and degeneration. J Neurosci. 2006;26(31):8057–8068. DOI:https://doi.org/10.1523/JNEUROSCI.2261-06.2006.
   PubMed Web of Science ®Google Scholar
• Komatsu M, Wang QJ, Holstein GR, et al. Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration. Proc Natl Acad Sci U S A. 2007;104(36):14489–14494. DOI:https://doi.org/10.1073/pnas.0701311104.
   PubMed Web of Science ®Google Scholar
• Shen W, Ganetzky B. Autophagy promotes synapse development in Drosophila. J Cell Biol. 2009;187(1):71–79.
   PubMed Web of Science ®Google Scholar
• Tang G, Gudsnuk K, Kuo SH, et al. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron. 2014;83(5):1131–1143. DOI:https://doi.org/10.1016/j.neuron.2014.07.040.
   PubMed Web of Science ®Google Scholar
• Boland B, Kumar A, Lee S, et al. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer’s disease. J Neurosci. 2008;28(27):6926–6937. DOI:https://doi.org/10.1523/JNEUROSCI.0800-08.2008.
   PubMed Web of Science ®Google Scholar
• Komatsu M, Waguri S, Chiba T, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441(7095):880–884. DOI:https://doi.org/10.1038/nature04723.
   PubMed Web of Science ®Google Scholar
• Hara T, Nakamura K, Matsui M, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441(7095):885–889. DOI:https://doi.org/10.1038/nature04724.
   PubMed Web of Science ®Google Scholar
• Stavoe AK, Gopal PP, Gubas A, et al. Expression of WIPI2B counteracts age-related decline in autophagosome biogenesis in neurons. Elife. 2019;8:8.
   Web of Science ®Google Scholar
• Mizushima N, Yamamoto A, Matsui M, et al. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell. 2004;15(3):1101–1111. DOI:https://doi.org/10.1091/mbc.e03-09-0704.
   PubMed Web of Science ®Google Scholar
• Tsvetkov AS, Miller J, Arrasate M, et al. A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model. Proc Natl Acad Sci U S A. 2010;107(39):16982–16987. DOI:https://doi.org/10.1073/pnas.1004498107.
   PubMed Web of Science ®Google Scholar
• Roscic A, Baldo B, Crochemore C, et al. Induction of autophagy with catalytic mTOR inhibitors reduces huntingtin aggregates in a neuronal cell model. J Neurochem. 2011;119(2):398–407. DOI:https://doi.org/10.1111/j.1471-4159.2011.07435.x.
   PubMed Web of Science ®Google Scholar
• Fox JH, Connor T, Chopra V, et al. The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington’s disease. Mol Neurodegener. 2010;5(1):26. DOI:https://doi.org/10.1186/1750-1326-5-26
   PubMed Web of Science ®Google Scholar
• Arriola Apelo SI, Neuman JC, Baar EL, et al. Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system. Aging Cell. 2016;15(1):28–38. DOI:https://doi.org/10.1111/acel.12405.
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274–293.
   PubMed Web of Science ®Google Scholar
• Von Bartheld CS, Bahney J, Herculano-Houzel S. The search for true numbers of neurons and glial cells in the human brain: a review of 150 years of cell counting. J Comp Neurol. 2016;524(18):3865–3895.
   PubMed Web of Science ®Google Scholar
• Jessen KR. Glial cells. Int J Biochem Cell Biol. 2004;36(10):1861–1867.
   PubMed Web of Science ®Google Scholar
• Von Bernhardi R, Eugenin-von Bernhardi J, Flores B, et al. Glial Cells and Integrity of the Nervous System. Adv Exp Med Biol. 2016;949:1–24.
   PubMed Web of Science ®Google Scholar
• Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119(1):7–35.
   PubMed Web of Science ®Google Scholar
• Yong VW, Yong FP, Olivier A, et al. Morphologic heterogeneity of human adult astrocytes in culture: correlation with HLA-DR expression. J Neurosci Res. 1990;27(4):678–688. DOI:https://doi.org/10.1002/jnr.490270428.
   PubMed Web of Science ®Google Scholar
• Miller RH, Zhang H, Fok-Seang J. Glial cell heterogeneity in the mammalian spinal cord. Perspect Dev Neurobiol. 1994;2(3):225–231.
   PubMedGoogle Scholar
• Miller RH, Raff MC. Fibrous and protoplasmic astrocytes are biochemically and developmentally distinct. J Neurosci. 1984;4(2):585–592.
   PubMed Web of Science ®Google Scholar
• Vaughn JE, Pease DC. Electron microscopy of classically stained astrocytes. J Comp Neurol. 1967;131(2):143–154.
   PubMed Web of Science ®Google Scholar
• Nedelsky NB, Todd PK, Taylor JP. Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection. Biochim Biophys Acta. 2008;1782(12):691–699.
   PubMed Web of Science ®Google Scholar
• Janen SB, Chaachouay H, Richter-Landsberg C. Autophagy is activated by proteasomal inhibition and involved in aggresome clearance in cultured astrocytes. Glia. 2010;58(14):1766–1774.
   PubMed Web of Science ®Google Scholar
• Tang G, Yue Z, Talloczy Z, et al. Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways. Hum Mol Genet. 2008;17(11):1540–1555. DOI:https://doi.org/10.1093/hmg/ddn042.
   PubMed Web of Science ®Google Scholar
• Pamenter ME, Perkins GA, McGinness AK, et al. Autophagy and apoptosis are differentially induced in neurons and astrocytes treated with an in vitro mimic of the ischemic penumbra. PLoS One. 2012;7(12):e51469. DOI:https://doi.org/10.1371/journal.pone.0051469.
   PubMed Web of Science ®Google Scholar
• Motori E, Puyal J, Toni N, et al. Inflammation-induced alteration of astrocyte mitochondrial dynamics requires autophagy for mitochondrial network maintenance. Cell Metab. 2013;18(6):844–859. DOI:https://doi.org/10.1016/j.cmet.2013.11.005.
   PubMed Web of Science ®Google Scholar
• Kulkarni A, Dong A, Kulkarni VV, et al. Differential regulation of autophagy during metabolic stress in astrocytes and neurons. Autophagy. 2019;16(9):1651–1667.
   PubMed Web of Science ®Google Scholar
• Lavieu G, Scarlatti F, Sala G, et al. Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation. J Biol Chem. 2006;281(13):8518–8527. DOI:https://doi.org/10.1074/jbc.M506182200.
   PubMed Web of Science ®Google Scholar
• Lima S, Milstien S, Spiegel S. Sphingosine and Sphingosine Kinase 1 Involvement in Endocytic Membrane Trafficking. J Biol Chem. 2017;292(8):3074–3088.
   PubMed Web of Science ®Google Scholar
• Moruno Manchon JF, Uzor NE, Finkbeiner S, et al. SPHK1/sphingosine kinase 1-mediated autophagy differs between neurons and SH-SY5Y neuroblastoma cells. Autophagy. 2016;12(8):1418–1424. DOI:https://doi.org/10.1080/15548627.2016.1183082.
   PubMed Web of Science ®Google Scholar
• Young MM, Takahashi Y, Fox TE, et al. Sphingosine Kinase 1 Cooperates with Autophagy to Maintain Endocytic Membrane Trafficking. Cell Rep. 2016;17(6):1532–1545. DOI:https://doi.org/10.1016/j.celrep.2016.10.019.
   PubMed Web of Science ®Google Scholar
• Koistinaho M, Lin S, Wu X, et al. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med. 2004;10(7):719–726. DOI:https://doi.org/10.1038/nm1058.
   PubMed Web of Science ®Google Scholar
• Nielsen HM, Veerhuis R, Holmqvist B, et al. Binding and uptake of A beta1-42 by primary human astrocytes in vitro. Glia. 2009;57(9):978–988. DOI:https://doi.org/10.1002/glia.20822.
   PubMed Web of Science ®Google Scholar
• Wyss-Coray T, Loike JD, Brionne TC, et al. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med. 2003;9(4):453–457. DOI:https://doi.org/10.1038/nm838.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Suk JE, Patrick C, et al. Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem. 2010;285(12):9262–9272. DOI:https://doi.org/10.1074/jbc.M109.081125.
   PubMed Web of Science ®Google Scholar
• Braidy N, Gai WP, Xu YH, et al. Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts. Transl Neurodegener. 2013;2(1):20. DOI:https://doi.org/10.1186/2047-9158-2-20.
   PubMedGoogle Scholar
• Lindstrom V, Gustafsson G, Sanders LH, et al. Extensive uptake of alpha-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage. Mol Cell Neurosci. 2017;82:143–156.
   PubMed Web of Science ®Google Scholar
• Chen LL, Wu JC, Wang LH, et al. Rapamycin prevents the mutant huntingtin-suppressed GLT-1 expression in cultured astrocytes. Acta Pharmacol Sin. 2012;33(3):385–392. DOI:https://doi.org/10.1038/aps.2011.162.
   PubMed Web of Science ®Google Scholar
• Bruijn LI, Becher MW, Lee MK, et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 1997;18(2):327–338. DOI:https://doi.org/10.1016/S0896-6273(00)80272-X.
   PubMed Web of Science ®Google Scholar
• Tripathi P, Rodriguez-Muela N, Klim JR, et al. Reactive astrocytes promote ALS-like degeneration and intracellular protein aggregation in human motor neurons by disrupting autophagy through TGF-beta1. Stem Cell Reports. 2017;9(2):667–680. DOI:https://doi.org/10.1016/j.stemcr.2017.06.008.
   PubMed Web of Science ®Google Scholar
• Hanamsagar R, Bilbo SD. Environment matters: microglia function and dysfunction in a changing world. Curr Opin Neurobiol. 2017;47:146–155.
   PubMed Web of Science ®Google Scholar
• Schafer DP, Stevens B. Microglia Function in Central Nervous System Development and Plasticity. Cold Spring Harb Perspect Biol. 2015;7(10):a020545.
   PubMed Web of Science ®Google Scholar
• Keren-Shaul H, Spinrad A, Weiner A, et al. A unique microglia type associated with restricting development of Alzheimer’s disease. Cell. 2017;169(7):1276–1290.e17. DOI:https://doi.org/10.1016/j.cell.2017.05.018.
   PubMed Web of Science ®Google Scholar
• Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011;10(3):253–263.
   PubMed Web of Science ®Google Scholar
• Gleichman AJ, Carmichael ST. Glia in neurodegeneration: drivers of disease or along for the ride?. Neurobiol Dis. 2020;142:104957.
   PubMed Web of Science ®Google Scholar
• Haukedal H, Freude K. Implications of Microglia in amyotrophic lateral sclerosis and frontotemporal dementia. J Mol Biol. 2019;431(9):1818–1829.
   PubMed Web of Science ®Google Scholar
• Thompson AG, Gray E, Thézénas ML, et al. Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis. Ann Neurol. 2018;83(2):258–268. DOI:https://doi.org/10.1002/ana.25143.
   PubMed Web of Science ®Google Scholar
• Corcia P, Tauber C, Vercoullie J, et al. Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLoS One. 2012;7(12):e52941. DOI:https://doi.org/10.1371/journal.pone.0052941.
   PubMed Web of Science ®Google Scholar
• Turner MR, Cagnin A, Turkheimer FE, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis. 2004;15(3):601–609. DOI:https://doi.org/10.1016/j.nbd.2003.12.012.
   PubMed Web of Science ®Google Scholar
• Cady J, Koval ED, Benitez BA, et al. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol. 2014;71(4):449–453. DOI:https://doi.org/10.1001/jamaneurol.2013.6237.
   PubMed Web of Science ®Google Scholar
• Colonna M. TREMs in the immune system and beyond. Nat Rev Immunol. 2003;3(6):445–453.
   PubMed Web of Science ®Google Scholar
• Kleinberger G, Yamanishi Y, Suárez-Calvet M, et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med. 2014;6(243):243ra86. DOI:https://doi.org/10.1126/scitranslmed.3009093.
   PubMed Web of Science ®Google Scholar
• Plaza-Zabala A, Sierra-Torre V, Sierra A. Autophagy and Microglia: novel Partners in Neurodegeneration and Aging. Int J Mol Sci. 2017;18(3):3.
   Web of Science ®Google Scholar
• Etchegaray JI, Elguero EJ, Tran JA, et al. Defective phagocytic corpse processing results in neurodegeneration and can be rescued by TORC1 activation. J Neurosci. 2016;36(11):3170–3183. DOI:https://doi.org/10.1523/JNEUROSCI.1912-15.2016.
   PubMed Web of Science ®Google Scholar
• Sierra A, Abiega O, Shahraz A, et al. Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. Front Cell Neurosci. 2013;7:6.
   PubMed Web of Science ®Google Scholar
• Solé-Domènech S, Cruz DL, Capetillo-Zarate E, et al. The endocytic pathway in microglia during health, aging and Alzheimer’s disease. Ageing Res Rev. 2016;32:89–103. DOI:https://doi.org/10.1016/j.arr.2016.07.002
   PubMed Web of Science ®Google Scholar
• Cho MH, Cho K, Kang HJ, et al. Autophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome. Autophagy. 2014;10(10):1761–1775. DOI:https://doi.org/10.4161/auto.29647.
   PubMed Web of Science ®Google Scholar
• Lucin KM, O’Brien CE, Bieri G, et al. Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer’s disease. Neuron. 2013;79(5):873–886. DOI:https://doi.org/10.1016/j.neuron.2013.06.046.
   PubMed Web of Science ®Google Scholar
• Haidet-phillips AM, Hester ME, Miranda CJ, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol. 2011;29(9):824–828. DOI:https://doi.org/10.1038/nbt.1957.
   PubMed Web of Science ®Google Scholar
• Henkel JS, Beers DR, Zhao W, et al. Microglia in ALS: the good, the bad, and the resting. J Neuroimmune Pharmacol. 2009;4(4):389–398. DOI:https://doi.org/10.1007/s11481-009-9171-5.
   PubMed Web of Science ®Google Scholar
• Yamanaka K, Chun SJ, Boillee S, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci. 2008;11(3):251–253. DOI:https://doi.org/10.1038/nn2047.
   PubMed Web of Science ®Google Scholar
• Beers DR, Henkel JS, Xiao Q, et al. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2006;103(43):16021–16026.
   PubMed Web of Science ®Google Scholar
• Brettschneider J, Toledo JB, Van Deerlin VM, et al. Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLoS One. 2012;7(6):e39216. DOI:https://doi.org/10.1371/journal.pone.0039216.
   PubMed Web of Science ®Google Scholar
• O’Rourke JG, Bogdanik L, Yáñez A, et al. C9orf72 is required for proper macrophage and microglial function in mice. Science. 2016;351(6279):1324–1329. DOI:https://doi.org/10.1126/science.aaf1064.
   PubMed Web of Science ®Google Scholar
• McCauley ME, O’Rourke JG, Yáñez A, et al. C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature. 2020;585(7823):96–101. DOI:https://doi.org/10.1038/s41586-020-2625-x.
   PubMed Web of Science ®Google Scholar
• Asai T, Tomita Y, Nakatsuka S, et al. VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn J Cancer Res. 2002;93(3):296–304. DOI:https://doi.org/10.1111/j.1349-7006.2002.tb02172.x.
   PubMedGoogle Scholar
• Duran A, Linares JF, Galvez AS, et al. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell. 2008;13(4):343–354. DOI:https://doi.org/10.1016/j.ccr.2008.02.001.
   PubMed Web of Science ®Google Scholar
• Zhu G, Wu CJ, Zhao Y, et al. Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP. Curr Biol. 2007;17(16):1438–1443. DOI:https://doi.org/10.1016/j.cub.2007.07.041.
   PubMed Web of Science ®Google Scholar
• Bankston AN, Forston MD, Howard RM, et al. Autophagy is essential for oligodendrocyte differentiation, survival, and proper myelination. Glia. 2019;67(9):1745–1759. DOI:https://doi.org/10.1002/glia.23646.
   PubMed Web of Science ®Google Scholar
• Dello Russo C, Lisi L, Feinstein DL, et al. mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis. Glia. 2013;61(3):301–311. DOI:https://doi.org/10.1002/glia.22433.
   PubMed Web of Science ®Google Scholar
• Figlia G, Gerber D, Suter U. Myelination and mTOR. Glia. 2018;66(4):693–707.
   PubMed Web of Science ®Google Scholar
• Tyler WA, Gangoli N, Gokina P, et al. Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation. J Neurosci. 2009;29(19):6367–6378. DOI:https://doi.org/10.1523/JNEUROSCI.0234-09.2009.
   PubMed Web of Science ®Google Scholar
• Smith CM, Mayer JA, Duncan ID. Autophagy promotes oligodendrocyte survival and function following dysmyelination in a long-lived myelin mutant. J Neurosci. 2013;33(18):8088–8100.
   PubMed Web of Science ®Google Scholar
• Saraswat Ohri S, Bankston AN, Mullins SA, et al. Blocking Autophagy in Oligodendrocytes Limits Functional Recovery after Spinal Cord Injury. J Neurosci. 2018;38(26):5900–5912. DOI:https://doi.org/10.1523/JNEUROSCI.0679-17.2018.
   PubMed Web of Science ®Google Scholar
• Pukaß K, Goldbaum O, Richter-Landsberg C. Mitochondrial impairment and oxidative stress compromise autophagosomal degradation of α-synuclein in oligodendroglial cells. J Neurochem. 2015;135(1):194–205.
   PubMed Web of Science ®Google Scholar
• Riedel M, Goldbaum O, Schwarz L, et al. 17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy. PLoS One. 2010;5(1):e8753. DOI:https://doi.org/10.1371/journal.pone.0008753.
   PubMed Web of Science ®Google Scholar
• Cong Y, Wang C, Wang J, et al. NT-3 promotes oligodendrocyte proliferation and nerve function recovery after spinal cord injury by inhibiting autophagy pathway. J Surg Res. 2020;247:128–135.
   PubMed Web of Science ®Google Scholar
• Liu S, Sarkar C, Dinizo M, et al. Disrupted autophagy after spinal cord injury is associated with ER stress and neuronal cell death. Cell Death Dis. 2015;6(1):e1582. DOI:https://doi.org/10.1038/cddis.2014.527.
   PubMed Web of Science ®Google Scholar
• Kaji S, Maki T, Kinoshita H, et al. Pathological endogenous alpha-synuclein accumulation in oligodendrocyte precursor cells potentially induces inclusions in multiple system atrophy. Stem Cell Reports. 2018;10(2):356–365. DOI:https://doi.org/10.1016/j.stemcr.2017.12.001.
   PubMed Web of Science ®Google Scholar
• Mackenzie IR, Ansorge O, Strong M, et al. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation. Acta Neuropathol. 2011;122(1):87–98. DOI:https://doi.org/10.1007/s00401-011-0838-7.
   PubMed Web of Science ®Google Scholar
• Mackenzie IR, Bigio EH, Ince PG, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007;61(5):427–434. DOI:https://doi.org/10.1002/ana.21147.
   PubMed Web of Science ®Google Scholar
• Seilhean D, Cazeneuve C, Thuries V, et al. Accumulation of TDP-43 and alpha-actin in an amyotrophic lateral sclerosis patient with the K17I ANG mutation. Acta Neuropathol. 2009;118(4):561–573. DOI:https://doi.org/10.1007/s00401-009-0545-9.
   PubMed Web of Science ®Google Scholar
• Lee Y, Morrison BM, Li Y, et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 2012;487(7408):443–448. DOI:https://doi.org/10.1038/nature11314.
   PubMed Web of Science ®Google Scholar
• Jang SY, Shin YK, Park SY, et al. Autophagy is involved in the reduction of myelinating Schwann cell cytoplasm during myelin maturation of the peripheral nerve. PLoS One. 2015;10(1):e0116624.
   PubMed Web of Science ®Google Scholar
• Logan AM, Mammel AE, Robinson DC, et al. Schwann cell-specific deletion of the endosomal PI 3-kinase Vps34 leads to delayed radial sorting of axons, arrested myelination, and abnormal ErbB2-ErbB3 tyrosine kinase signaling. Glia. 2017;65(9):1452–1470. DOI:https://doi.org/10.1002/glia.23173.
   PubMed Web of Science ®Google Scholar
• Zhang SJ, Li XX, Yu Y, et al. Schwann cell-specific PTEN and EGFR dysfunctions affect neuromuscular junction development by impairing Agrin signaling and autophagy. Biochem Biophys Res Commun. 2019;515(1):50–56. DOI:https://doi.org/10.1016/j.bbrc.2019.05.014.
   PubMed Web of Science ®Google Scholar
• Brosius Lutz A, Chung WS, Sloan SA, et al. Schwann cells use TAM receptor-mediated phagocytosis in addition to autophagy to clear myelin in a mouse model of nerve injury. Proc Natl Acad Sci U S A. 2017;114(38):E8072–e8080. DOI:https://doi.org/10.1073/pnas.1710566114.
   PubMed Web of Science ®Google Scholar
• Gomez-Sanchez JA, Carty L, Iruarrizaga-Lejarreta M, et al. Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves. J Cell Biol. 2015;210(1):153–168. DOI:https://doi.org/10.1083/jcb.201503019.
   PubMed Web of Science ®Google Scholar
• Jang SY, Yoon BA, Shin YK, et al. Schwann cell dedifferentiation-associated demyelination leads to exocytotic myelin clearance in inflammatory segmental demyelination. Glia. 2017;65(11):1848–1862. DOI:https://doi.org/10.1002/glia.23200.
   PubMed Web of Science ®Google Scholar
• Huang HC, Chen L, Zhang HX, et al. Autophagy promotes peripheral nerve regeneration and motor recovery following sciatic nerve crush injury in rats. J Mol Neurosci. 2016;58(4):416–423. DOI:https://doi.org/10.1007/s12031-015-0672-9.
   PubMed Web of Science ®Google Scholar
• Marinelli S, Nazio F, Tinari A, et al. Schwann cell autophagy counteracts the onset and chronification of neuropathic pain. Pain. 2014;155(1):93–107. DOI:https://doi.org/10.1016/j.pain.2013.09.013.
   PubMed Web of Science ®Google Scholar
• Hantke J, Carty L, Wagstaff LJ, et al. c-Jun activation in Schwann cells protects against loss of sensory axons in inherited neuropathy. Brain. 2014;137(11):2922–2937. DOI:https://doi.org/10.1093/brain/awu257.
   PubMed Web of Science ®Google Scholar
• Hutton EJ, Carty L, Laura M, et al. c-Jun expression in human neuropathies: a pilot study. J Peripher Nerv Syst. 2011;16(4):295–303. DOI:https://doi.org/10.1111/j.1529-8027.2011.00360.x.
   PubMed Web of Science ®Google Scholar
• Lee S, Bazick H, Chittoor-Vinod V, et al. Elevated peripheral myelin protein 22, reduced mitotic potential, and proteasome impairment in dermal fibroblasts from charcot-marie-tooth disease type 1A patients. Am J Pathol. 2018;188(3):728–738. DOI:https://doi.org/10.1016/j.ajpath.2017.10.021.
   PubMed Web of Science ®Google Scholar
• Chow CY, Landers JE, Bergren SK, et al. Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet. 2009;84(1):85–88. DOI:https://doi.org/10.1016/j.ajhg.2008.12.010.
   PubMed Web of Science ®Google Scholar
• Fernandez AM, LeRoith D. Skeletal muscle. Adv Exp Med Biol. 2005;567:117–147.
   PubMed Web of Science ®Google Scholar
• Wang X, Blagden C, Fan J, et al. Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle. Genes Dev. 2005;19(14):1715–1722. DOI:https://doi.org/10.1101/gad.1318305.
   PubMed Web of Science ®Google Scholar
• Mammucari C, Milan G, Romanello V, et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 2007;6(6):458–471. DOI:https://doi.org/10.1016/j.cmet.2007.11.001.
   PubMed Web of Science ®Google Scholar
• Campos JC, Baehr LM, Ferreira ND, et al. beta2 -adrenoceptor activation improves skeletal muscle autophagy in neurogenic myopathy. Faseb J. 2020;34(4):5628–5641. DOI:https://doi.org/10.1096/fj.201902305R.
   PubMed Web of Science ®Google Scholar
• Nichenko AS, Southern WM, Atuan M, et al. Mitochondrial maintenance via autophagy contributes to functional skeletal muscle regeneration and remodeling. Am J Physiol Cell Physiol. 2016;311(2):C190–200. DOI:https://doi.org/10.1152/ajpcell.00066.2016.
   PubMed Web of Science ®Google Scholar
• Saera-Vila A, Kish PE, Louie KW, et al. Autophagy regulates cytoplasmic remodeling during cell reprogramming in a zebrafish model of muscle regeneration. Autophagy. 2016;12(10):1864–1875. DOI:https://doi.org/10.1080/15548627.2016.1207015.
   PubMed Web of Science ®Google Scholar
• Masiero E, Agatea L, Mammucari C, et al. Autophagy is required to maintain muscle mass. Cell Metab. 2009;10(6):507–515. DOI:https://doi.org/10.1016/j.cmet.2009.10.008.
   PubMed Web of Science ®Google Scholar
• Raben N, Hill V, Shea L, et al. Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease. Hum Mol Genet. 2008;17(24):3897–3908. DOI:https://doi.org/10.1093/hmg/ddn292.
   PubMed Web of Science ®Google Scholar
• Dobrowolny G, Aucello M, Rizzuto E, et al. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 2008;8(5):425–436. DOI:https://doi.org/10.1016/j.cmet.2008.09.002.
   PubMed Web of Science ®Google Scholar
• Bibee KP, Cheng YJ, Ching JK, et al. Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function. Faseb J. 2014;28(5):2047–2061. DOI:https://doi.org/10.1096/fj.13-237388.
   PubMed Web of Science ®Google Scholar
• Pauly M, Daussin F, Burelle Y, et al. AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm. Am J Pathol. 2012;181(2):583–592. DOI:https://doi.org/10.1016/j.ajpath.2012.04.004.
   PubMed Web of Science ®Google Scholar
• Salminen A, Vihko V. Autophagic response to strenuous exercise in mouse skeletal muscle fibers. Virchows Arch B Cell Pathol Incl Mol Pathol. 1984;45(1):97–106.
   PubMedGoogle Scholar
• Fry CS, Drummond MJ, Glynn EL, et al. Skeletal muscle autophagy and protein breakdown following resistance exercise are similar in younger and older adults. J Gerontol A Biol Sci Med Sci. 2013;68(5):599–607. DOI:https://doi.org/10.1093/gerona/gls209.
   PubMed Web of Science ®Google Scholar
• Moller AB, Vendelbo MH, Christensen B, et al. Physical exercise increases autophagic signaling through ULK1 in human skeletal muscle. J Appl Physiol. 1985;118(8):971–979. DOI:https://doi.org/10.1152/japplphysiol.01116.2014.
   Web of Science ®Google Scholar
• He C, Bassik MC, Moresi V, et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature. 2012;481(7382):511–515. DOI:https://doi.org/10.1038/nature10758.
   PubMed Web of Science ®Google Scholar
• Jamart C, Francaux M, Millet GY, et al. Modulation of autophagy and ubiquitin-proteasome pathways during ultra-endurance running. J Appl Physiol (1985). 2012;112(9):1529–1537. DOI:https://doi.org/10.1152/japplphysiol.00952.2011
   PubMed Web of Science ®Google Scholar
• Jamart C, Benoit N, Raymackers JM, et al. Autophagy-related and autophagy-regulatory genes are induced in human muscle after ultraendurance exercise. Eur J Appl Physiol. 2012;112(8):3173–3177. DOI:https://doi.org/10.1007/s00421-011-2287-3.
   PubMed Web of Science ®Google Scholar
• Vainshtein A, Tryon LD, Pauly M, et al. Role of PGC-1alpha during acute exercise-induced autophagy and mitophagy in skeletal muscle. Am J Physiol Cell Physiol. 2015;308(9):C710–9.
   PubMed Web of Science ®Google Scholar
• Fan J, Kou X, Jia S, et al. Autophagy as a Potential Target for Sarcopenia. J Cell Physiol. 2016;231(7):1450–1459. DOI:https://doi.org/10.1002/jcp.25260.
   PubMed Web of Science ®Google Scholar
• Demontis F, Perrimon N. FOXO/4E-BP signaling in Drosophila muscles regulates organism-wide proteostasis during aging. Cell. 2010;143(5):813–825.
   PubMed Web of Science ®Google Scholar
• Kim YA, Kim YS, Oh SL, et al. Autophagic response to exercise training in skeletal muscle with age. J Physiol Biochem. 2013;69(4):697–705. DOI:https://doi.org/10.1007/s13105-013-0246-7.
   PubMed Web of Science ®Google Scholar
• Sebastian D, Sorianello E, Segales J, et al. Mfn2 deficiency links age-related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway. Embo J. 2016;35(15):1677–1693. DOI:https://doi.org/10.15252/embj.201593084.
   PubMed Web of Science ®Google Scholar
• Halling JF, Ringholm S, Olesen J, et al. Exercise training protects against aging-induced mitochondrial fragmentation in mouse skeletal muscle in a PGC-1alpha dependent manner. Exp Gerontol. 2017;96:1–6.
   PubMed Web of Science ®Google Scholar
• Russ DW, Boyd IM, McCoy KM, et al. Muscle-specificity of age-related changes in markers of autophagy and sphingolipid metabolism. Biogerontology. 2015;16(6):747–759. DOI:https://doi.org/10.1007/s10522-015-9598-4.
   PubMed Web of Science ®Google Scholar
• Wenz T, Rossi SG, Rotundo RL, et al. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci U S A. 2009;106(48):20405–20410. DOI:https://doi.org/10.1073/pnas.0911570106.
   PubMed Web of Science ®Google Scholar
• O’Leary MF, Vainshtein A, Iqbal S, et al. Adaptive plasticity of autophagic proteins to denervation in aging skeletal muscle. Am J Physiol Cell Physiol. 2013;304(5):C422–30. DOI:https://doi.org/10.1152/ajpcell.00240.2012.
   PubMed Web of Science ®Google Scholar
• Carter HN, Kim Y, Erlich AT, et al. Autophagy and mitophagy flux in young and aged skeletal muscle following chronic contractile activity. J Physiol. 2018;596(16):3567–3584. DOI:https://doi.org/10.1113/JP275998.
   PubMed Web of Science ®Google Scholar
• Mandrioli J, D’Amico R, Zucchi E, et al. Rapamycin treatment for amyotrophic lateral sclerosis: protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial). Medicine (Baltimore). 2018;97(24):e11119. DOI:https://doi.org/10.1097/MD.0000000000011119.
   PubMed Web of Science ®Google Scholar
• Li M, Zhou Y, Chen C, et al. Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis. Orphanet J Rare Dis. 2019;14(1):39. DOI:https://doi.org/10.1186/s13023-019-1012-x.
   PubMed Web of Science ®Google Scholar
• Lutz M, Mielke S. New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease. Br J Clin Pharmacol. 2016;82(5):1171–1179.
   PubMed Web of Science ®Google Scholar
• Nguyen LS, Vautier M, Allenbach Y, et al. Sirolimus and mTOR Inhibitors: a Review of Side Effects and Specific Management in Solid Organ Transplantation. Drug Saf. 2019;42(7):813–825. DOI:https://doi.org/10.1007/s40264-019-00810-9.
   PubMed Web of Science ®Google Scholar
• Sofroniadou S, Goldsmith D. Mammalian target of rapamycin (mTOR) inhibitors: potential uses and a review of haematological adverse effects. Drug Saf. 2011;34(2):97–115.
   PubMed Web of Science ®Google Scholar
• Pallet N, Legendre C. Adverse events associated with mTOR inhibitors. Expert Opin Drug Saf. 2013;12(2):177–186.
   PubMed Web of Science ®Google Scholar
• Kahan BD, Napoli KL, Kelly PA, et al. Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity. Clin Transplant. 2000;14(2):97–109. DOI:https://doi.org/10.1034/j.1399-0012.2000.140201.x.
   PubMed Web of Science ®Google Scholar
• Fornai F, Longone P, Cafaro L, et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2008;105(6):2052–2057. DOI:https://doi.org/10.1073/pnas.0708022105.
   PubMed Web of Science ®Google Scholar
• Fornai F, Longone P, Ferrucci M, et al. Autophagy and amyotrophic lateral sclerosis: the multiple roles of lithium. Autophagy. 2008;4(4):527–530. DOI:https://doi.org/10.4161/auto.5923.
   PubMed Web of Science ®Google Scholar
• Aggarwal SP, Zinman L, Simpson E, et al. Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010;9(5):481–488. DOI:https://doi.org/10.1016/S1474-4422(10)70068-5.
   PubMed Web of Science ®Google Scholar
• Chio A, Borghero G, Calvo A, et al. Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial. Neurology. 2010;75(7):619–625. DOI:https://doi.org/10.1212/WNL.0b013e3181ed9e7c.
   PubMed Web of Science ®Google Scholar
• Miller RG, Moore DH, Forshew DA, et al. Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design. Neurology. 2011;77(10):973–979. DOI:https://doi.org/10.1212/WNL.0b013e31822dc7a5.
   PubMed Web of Science ®Google Scholar
• Morrison KE, Dhariwal S, Hornabrook R, et al. Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2013;12(4):339–345.
   PubMed Web of Science ®Google Scholar
• Verstraete E, Veldink JH, Huisman MH, et al. Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb randomised sequential trial. J Neurol Neurosurg Psychiatry. 2012;83(5):557–564. DOI:https://doi.org/10.1136/jnnp-2011-302021.
   PubMed Web of Science ®Google Scholar
• Kanazawa T, Taneike I, Akaishi R, et al. Amino acids and insulin control autophagic proteolysis through different signaling pathways in relation to mTOR in isolated rat hepatocytes. J Biol Chem. 2004;279(9):8452–8459. DOI:https://doi.org/10.1074/jbc.M306337200.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Marino G, Levine B. Autophagy and the integrated stress response. Mol Cell. 2010;40(2):280–293.
   PubMed Web of Science ®Google Scholar
• Wang RC, Wei Y, An Z, et al. Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science. 2012;338(6109):956–959. DOI:https://doi.org/10.1126/science.1225967.
   PubMed Web of Science ®Google Scholar
• Wei Y, Pattingre S, Sinha S, et al. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol Cell. 2008;30(6):678–688. DOI:https://doi.org/10.1016/j.molcel.2008.06.001.
   PubMed Web of Science ®Google Scholar
• Shoji-Kawata S, Sumpter R, Leveno M, et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature. 2013;494(7436):201–206. DOI:https://doi.org/10.1038/nature11866.
   PubMed Web of Science ®Google Scholar
• Wengrod J, Martin L, Wang D, et al. Inhibition of nonsense-mediated RNA decay activates autophagy. Mol Cell Biol. 2013;33(11):2128–2135. DOI:https://doi.org/10.1128/MCB.00174-13.
   PubMed Web of Science ®Google Scholar
• Daub A, Sharma P, Finkbeiner S. High-content screening of primary neurons: ready for prime time. Curr Opin Neurobiol. 2009;19(5):537–543.
   PubMed Web of Science ®Google Scholar
• Engle SJ, Vincent F. Small molecule screening in human induced pluripotent stem cell-derived terminal cell types. J Biol Chem. 2014;289(8):4562–4570.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Perlstein EO, Imarisio S, et al. Small molecules enhance autophagy and reduce toxicity in Huntington’s disease models. Nat Chem Biol. 2007;3(6):331–338. DOI:https://doi.org/10.1038/nchembio883.
   PubMed Web of Science ®Google Scholar